Liquid-crystal medium

Abstract

A liquid-crystal (LC) material having negative dielectric anisotropy and the use thereof for optical, electro-optical and electronic purposes, such as for example in energy-efficient LC displays, in particular displays based on the electrically controlled birefringence (ECB), IPS, or FFS effect.

Claims

1. A liquid crystal medium comprising: a) one or more compounds of formula ST: ##STR00571## in which R.sup.S1 denotes a straight-chain alkyl radical having 1 to 12 C atoms or a branched alkyl radical having 3 to 12 C atoms, where one or more CH.sub.2 groups in these radicals may each be replaced, independently of one another, by ##STR00572## CC, CF.sub.2O, OCF.sub.2, CHCH, O, COO, or OCO in such a way that O atoms are not linked directly to one another, and in which one or more H atoms may be replaced by halogen; R.sup.S2 denotes H, an alkyl or alkoxy having 1 to 7 C atoms, or an alkenyl having 2 to 7 C atoms, where one or more H atoms in these radials may be replaced by halogen; W.sup.1, W.sup.2, W.sup.3, and W.sup.4 identically or differently, denote an O or CH.sub.2; and r1 and r2 independently are 0 or 1; b) one or more compounds of formula Ia: ##STR00573## in which W denotes CH.sub.4-s, an aromatic hydrocarbon group having 6 to 40 C atoms, or a heteroaromatic hydrocarbon group having 4 to 40 C atoms; A on each occurrence, identically or differently, denotes a single bond, a straight-chain alkyl radical having 1 to 20 C atoms, a straight-chain alkenylene radical having 2 to 20 C atoms, or a branched alkylene or alkenylene radical having 3 to 12 C atoms, where one or more CH.sub.2 groups in these radicals may each be replaced, independently of one another, by CC, CHCH, C(O), O, COO, or OCO in such a way that O atoms are not linked directly to one another, in which one or more H atoms may be replaced by halogen, and in which one or two H atoms may be replaced by a group Z.sup.S-HA.sup.a; R.sup.S denotes H, an alkyl having 1 to 12 C atoms, or an alkenyl having 2 to 12 C atoms; Z.sup.S denotes O, C(O)O, (CH.sub.2).sub.z, (CH.sub.2).sub.zO, or a single bond; HA.sup.a denotes ##STR00574## R.sup.S1, R.sup.S2, R.sup.S3 and R.sup.S4 identically or differently, denote an alkyl having 1 to 6 C atoms; G denotes H, R.sup.S, or a group Z.sup.S-HA.sup.a; z is an integer from 1 to 6; and s is 2, 3, or 4; c) one or more compounds of formula Ib: ##STR00575## W denotes CH.sub.4-s, an aromatic hydrocarbon group having 6 to 40 C atoms, or a heteroaromatic hydrocarbon group having 4 to 40 C atoms; A on each occurrence, identically or differently, denotes a single bond, a straight-chain alkylene radical having 1 to 20 C atoms, a straight-chain alkenylene radical having 2 to 20 C atoms, or a branched alkylene or alkenylene radical having 3 to 12 C atoms, where one or more CH.sub.2 groups in these radicals may each be replaced, independently of one another, by CC, CHCH, C(O), O, COO, or OCO in such a way that O atoms are not linked directly to one another, and in which one or more H atoms may be replaced by halogen, and in which one or two H atoms may be replaced by a group Z.sup.S-HA.sup.b; R.sup.S denotes H, an alkyl having 1 to 12 C atoms, or an alkenyl having 2 to 12 C atoms; Z.sup.S denotes O, C(O)O, (CH.sub.2).sub.z or (CH.sub.2).sub.zO, or a single bond; HA.sup.b denotes ##STR00576## R.sup.S1, R.sup.S2, R.sup.S3 and R.sup.S4 identically or differently, denote an alkyl having 1 to 6 C atoms; G denotes H, R.sup.S, or a group Z.sup.S-HA.sup.b; z is an integer from 1 to 6; and s is 2, 3, or 4; and d) one or more compounds selected from the group of compounds of formulae IIA, IIB, IIC and IID: ##STR00577## in which R.sup.2A, R.sup.2B, R.sup.2C and R.sup.2D identically or differently, denote H, a straight-chain alkyl or alkoxy having 1 to 15 C atoms, a straight-chain alkenyl or alkenyloxy having 2 to 15 C atoms, or a branched alkyl, alkoxy, alkenyl, or alkenyloxy having 3 to 15 C atoms, where one or more CH.sub.2 groups in these radicals may each be replaced, independently of one another, by ##STR00578## CHCH, CC, CF.sub.2O, OCF.sub.2, O, COO, or OCO in such a way that O atoms are not linked directly to one another, and in which one or more H atoms may be replaced by halogen; L.sup.1 and L.sup.2 each, independently of one another, denote F, Cl, CF.sub.3, or CHF.sub.2, Y denotes H, F, Cl, CF.sub.3, CHF.sub.2 or CH.sub.3, Z.sup.2, Z.sup.2B, and Z.sup.2D each, independently of one another, denote a single bond, CH.sub.2CH.sub.2, CHCH, CF.sub.2O, OCF.sub.2, CH.sub.2O, OCH.sub.2, COO, OCO, C.sub.2F.sub.4, CFCF, or CHCHCH.sub.2O; (O) denotes O or a single bond; p denotes 0, 1 or 2; q denotes 0 or 1; and v denotes an integer from 1 to 6.

2. The liquid crystal medium according to claim 1, wherein the compounds of the formula ST are selected from the compounds of the formula ST-1 and ST-2: ##STR00579## in which R.sup.S1 denotes a straight-chain alkyl radical having 1 to 12 C atoms or a branched alkyl radical having 3 to 12 C atoms, where one or more CH.sub.2 groups in these radicals may each be replaced, independently of one another, by ##STR00580## CC, CF.sub.2O, OCF.sub.2, CHCH, O, COO, or OCO in such a way that O atoms are not linked directly to one another, and in which one or more H atoms may be replaced by halogen; and r is 0 or 1.

3. The liquid crystal medium according to claim 1, wherein the medium comprises one or more compounds of formula Ia selected from compounds of formula Ia-1: ##STR00581## in which R.sup.S3 denotes H or alkyl having 1 to 6 C atoms; t is 0 or 1; and q is 0, 1, 2, 3, 4, 5, 6, 7, 8, or 9.

4. The liquid crystal medium according to claim 1, wherein the compounds of the formula Ib are selected from compounds of formulae Ib-1, Ib-2, Ib-3, and Ib-4: ##STR00582## ##STR00583## in which R.sup.S3 denotes H or alkyl having 1 to 6 C atoms; t is 0 or 1; q is 0, 1, 2, 3, 4, 5, 6, 7, 8, or 9; A on each occurrence, identically or differently, denotes a single bond, a straight-chain alkylene radical having 1 to 20 C atoms, a straight-chain alkenylene radical having 2 to 20 C atoms, or a branched alkylene or alkenylene radical having 3 to 12 C atoms, where one or more CH.sub.2 groups in these radicals may each be replaced, independently of one another, by CC, CHCH, C(O), O, COO, or OCO in such a way that O atoms are not linked directly to one another, and in which one or more H atoms may be replaced by halogen and in which one or two H atoms may be replaced by a group Z.sup.S-HA.sup.b; R.sup.S denotes H, alkyl having 1 to 12 C atoms, or alkenyl having 2 to 12 C atoms; and W.sup.1 denotes a linear, optionally unsaturated, alkylene having 1 to 12 C atoms, or a branched, optionally unsaturated, alkylene having 3 to 12 C atoms, in which one or more non-adjacent CH.sub.2 groups may be replaced with O.

5. The liquid crystal medium according to claim 1, wherein the medium comprises one or more compounds of formula IID.

6. The liquid crystal medium according to claim 5, wherein the compounds of the formula IID are selected from compounds of the formulae IID-4 and IID-10: ##STR00584## in which alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms; and (O) denotes an oxygen atom or a single bond.

7. The liquid crystal medium according to claim 1, wherein the medium comprises one or more compounds of the formula III: ##STR00585## in which R.sup.31 and R.sup.32 each, independently of one another, denote H or an alkyl or alkoxy radical having 1 to 15 C atoms, where one or more CH.sub.2 groups in these radicals may each be replaced, independently of one another, by ##STR00586## CC, CF.sub.2O, OCF.sub.2, CHCH, by O, COO, or OCO in such a way that O atoms are not linked directly to one another, and in which one or more H atoms may be replaced by halogen; A.sup.31 on each occurrence, independently of one another, denotes a) 1,4-cyclohexenylene or 1,4-cyclohexylene radical, in which one or two non-adjacent CH.sub.2 groups may be replaced by O or S; b) a 1,4-phenylene radical, in which one or two CH groups may be replaced by N; or c) a radical from the group spiro[3.3]heptane-2,6-diyl, 1,4-bicyclo[2.2.2]octylene, naphthalene-2,6-diyl, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, phenanthrene-2,7-diyl, and fluorene-2,7-diyl, where the radicals a), b), or c) may be mono- or polysubstituted by halogen atoms; Z.sup.31 on each occurrence independently of one another denotes COO, OCO, CF.sub.2O, OCF.sub.2, CH.sub.2O, OCH.sub.2, CH.sub.2, CH.sub.2CH.sub.2, (CH.sub.2).sub.4, CHCHCH.sub.2O, C.sub.2F.sub.4, CH.sub.2CF.sub.2, CF.sub.2CH.sub.2, CFCF, CHCF, CFCH, CHCH, CC, or a single bond; n denotes 0, 1 or 2, L.sup.31 and L.sup.32 each, independently of one another, denote F, Cl, CF.sub.3, or CHF.sub.2; and W denotes O or S.

8. The liquid crystal medium according to claim 1, wherein the medium comprises one or more compounds of formula IIA-Y: ##STR00587## in which R.sup.11 and R.sup.12 identically or differently, denote H, a straight-chain alkyl or alkoxy having 1 to 15 C atoms, a straight-chain alkenyl or alkenyloxy having 2 to 15 C atoms, or a branched alkyl, alkoxy, alkenyl, or alkenyloxy having 3 to 15 C atoms, where one or more CH.sub.2 groups in these radicals may each be replaced, independently of one another, by ##STR00588## CHCH, CC, CF.sub.2O, OCF.sub.2, O, COO, or OCO in such a way that O atoms are not linked directly to one another, and in which one or more H atoms may be replaced by halogen; and L.sup.1 and L.sup.2 identically or differently, denote F or Cl.

9. The medium according to claim 1, wherein the medium comprises one or more compounds selected from the group of compounds of formulae BC, CR, PH-1, and PH-2: ##STR00589## in which R.sup.B1, R.sup.B2, R.sup.CR1, R.sup.CR2, R.sup.P1 and R.sup.P2 each, independently of one another, denote H or an alkyl or alkoxy radical having 1 to 15 C atoms, where one or more CH.sub.2 groups in these radicals may each be replaced, independently of one another, by ##STR00590## CC, CF.sub.2O, OCF.sub.2, CHCH, O, COO, or OCO in such a way that O atoms are not linked directly to one another, and in which one or more H atoms may be replaced by halogen; and c is 0, 1 or 2.

10. The liquid crystal medium according to claim 1, wherein the medium comprises one or more compounds of the formula IV: ##STR00591## in which R.sup.41 denotes an unsubstituted alkyl radical having 1 to 7 C atoms or an unsubstituted alkenyl radical having 2 to 7 C atoms; and R.sup.42 denotes an unsubstituted alkyl radical having 1 to 7 C atoms, an unsubstituted alkoxy radical having 1 to 6 C atoms, or an unsubstituted alkenyl radical having 2 to 7 C atoms.

11. The liquid crystal medium according to claim 1, wherein the medium comprises one or more additives selected from dichroic dyes, chiral dopants, and polymerizable compounds.

12. A liquid crystal display comprising the liquid crystal medium according to claim 1.

13. The liquid crystal display according to claim 12, wherein the display is a VA, IPS, or FFS type display.

14. The liquid crystal display according to claim 12, wherein the display is a VA, IPS, FFS, PS-VA, PS-IPS, or PS-FFS display.

15. A process of preparing a liquid crystal medium according to claim 1, comprising the steps of mixing one or more compounds of formula ST with one or more compounds of the formula Ia, with one or more compounds of the formula Ib, and with one or more compounds selected from the group of compounds of the formulae IIA, IIB, IIC and IID, and optionally with one or more liquid crystal compounds or additives.

Description

DETAILED DESCRIPTION

[0082] Preferred compounds of the formula ST are the compounds selected from the group of compounds of the formulae ST-1, ST-2, and ST-3, preferably of the formulae ST-1 and ST-2:

##STR00009## [0083] in which [0084] R.sup.S1 has the meanings given above and preferably denotes straight-chain, branched, or cyclic alkyl having 1 to 7 C atoms; and [0085] r is 0 or 1, preferably 0.

[0086] The compounds of the formulae ST-1 and ST-2 are preferably selected from the following sub-formulae:

##STR00010## ##STR00011## ##STR00012##

[0087] Preferred compounds of the formula ST-3 are ST-3a and ST-3b:

##STR00013##

[0088] The compounds of formula Ia and Ib are described in EP3354710 A1 and EP3354709 A1, respectively.

[0089] In a preferred embodiment, the group W in formula Ia denotes methylene and s is 2. In this embodiment, the compounds of formula Ia are preferably selected from the compounds of the formula Ia-1:

##STR00014## [0090] in which [0091] R.sup.S3 denotes H or alkyl having 1 to 6 C atoms, preferably H or ethyl; [0092] t is 0 or 1; and [0093] q is 0, 1, 2, 3, 4, 5, 6, 7, 8, or 9.

[0094] Very preferably, the compounds of formula Ia-1 are selected from the compounds of the formulae Ia-1-1 and Ia-1-2, in particular of the formula Ia-1-1

##STR00015## [0095] in which q is 0, 1, 2, 3, 4, 5, 6, 7, 8, or 9, preferably 1.

[0096] In a preferred embodiment, the group W in formula Ia denotes an aromatic or heteroaromatic hydrocarbon group having 4 to 40 C atoms, comprising one, two, three or four aromatic rings including condensed rings that may be linked directly or via an alkylene linking group having 1 to 12 C atoms, in which one or more H atoms are optionally replaced with alkyl or alkoxy having 1 to 6 C atoms or alkenyl having 2 to 6 C atoms, or with CN, CF.sub.3, or halogen, and in which one or more CH.sub.2 groups may each, independently of one another, be replaced by O, S, NH, N(C.sub.1-C.sub.4-alkyl)-, CO, COO, OCO, OCOO, CHCH, or CC in such a way that O or S atoms are not linked directly to one another.

[0097] Preferred aryl groups are benzene, naphthalene, anthracene, biphenyl, m-terphenyl, p-terphenyl, and (phenylalkyl)benzene in which alkyl is straight-chain alkyl having 1 to 12 C atoms.

[0098] In this embodiment, the compounds of formula Ia are preferably selected from the compounds of the formula Ia-2, Ia-3, Ia-4, and Ia-5:

##STR00016## [0099] in which [0100] HA denotes H or HA.sup.a, and HA.sup.a, A, and R.sup.S on each occurrence, identically or differently, have the meanings defined above; [0101] W.sup.1 denotes linear, optionally unsaturated alkylene having 1 to 12 C atoms, or branched, optionally unsaturated alkylene having 3 to 12 C atoms, in which one or more non-adjacent CH.sub.2 groups may be replaced with O; and [0102] n independently denotes 0, 1, 2, 3, or 4.

[0103] Preferred compounds of formula Ia-2 are selected from the compounds of the formula Ia-2-1:

##STR00017## [0104] in which n is an integer from 0 to 12, preferably 5, 6, 7, 8, or 9, very preferably 7.

[0105] Preferred compounds of formula Ia-3 are selected from the compounds of the formula Ia-3-1:

##STR00018## [0106] in which [0107] n2 on each occurrence identically or differently, preferably identically, is an integer from 1 to 12, preferably 2, 3, 4, 5, or 6, very preferably 3; and [0108] R.sup.S on each occurrence identically or differently, preferably identically, denotes alkyl having 1 to 6 C atoms, very preferably n-butyl.

[0109] Preferred compounds of formula Ia-4 are selected from the compounds of the formula Ia-4-1:

##STR00019## [0110] in which [0111] A and R.sup.S have the meanings defined above; and preferably [0112] A on each occurrence identically or differently, preferably identically, denotes alkylene having 1 to 12, preferably 2, 3, 4, 5, or 6, very preferably 3, C atoms; and [0113] R.sup.S on each occurrence identically or differently, preferably identically, denotes alkyl having 1 to 6 C atoms, very preferably n-butyl, and n is an integer from 0 to 12, preferably 5, 6, 7, 8, or 9, very preferably 7.

[0114] Specific very preferred compounds of the formula Ia are listed below:

##STR00020## ##STR00021## ##STR00022##

[0115] In a preferred embodiment, the group W in formula Ib denotes methylene and s is 2. In this embodiment, the compounds of formula Ib are preferably selected from the compounds of the formula Ib-1:

##STR00023## [0116] in which [0117] R.sup.S3 denotes H or alkyl having 1 to 6 C atoms, preferably H or ethyl; [0118] t is 0 or 1; and [0119] q is 0, 1, 2, 3, 4, 5, 6, 7, 8, or 9.

[0120] Very preferably, the compounds of formula Ib-1 are selected from the compounds of the formulae Ib-1-1 and Ib-1-2:

##STR00024## [0121] in which q is 0, 1, 2, 3, 4, 5, 6, 7, 8, or 9, preferably 7.

[0122] Alternatively, the group W in formula Ib denotes an aromatic or heteroaromatic hydrocarbon group having 4 to 40 C atoms, comprising one, two, three, or four aromatic rings including condensed rings that may be linked directly or via an alkylene linking group having 1 to 12 C atoms, in which one or more H atoms are optionally replaced with alkyl or alkoxy having 1 to 6 C atoms or alkenyl having 2 to 6 C atoms, or with CN, CF.sub.3, or halogen, and in which one or more CH.sub.2 groups may each, independently of one another, be replaced by O, S, NH, N(C.sub.1-C.sub.4-alkyl)-, CO, COO, OCO, OCOO, CHCH, or CC in such a way that O or S atoms are not linked directly to one another.

[0123] Preferred aryl groups are benzene, naphthalene, anthracene, biphenyl, m-terphenyl, p-terphenyl, and (phenylalkyl)benzene in which alkyl is straight-chain alkyl having 1 to 12 C atoms.

[0124] In this embodiment, the compounds of formula Ib are preferably selected from the compounds of the formula Ib-2, Ib-3, Ib-4, and Ib-5:

##STR00025## [0125] in which [0126] HA denotes H or HA.sup.b; and [0127] HA.sup.b, A, and R.sup.S on each occurrence, identically or differently, have the meanings defined above; [0128] W.sup.1 denotes linear or branched, optionally unsaturated alkylene having 1 to 12 C atoms, in which one or more non-adjacent CH.sub.2 groups may be replaced with O; and [0129] n independently denotes 0, 1, 2, 3, or 4.

[0130] Preferred compounds of formula Ib-2 are selected from the compounds of the formula Ia-2-1:

##STR00026## [0131] in which n is an integer from 0 to 12, preferably 5, 6, 7, 8, or 9, very preferably 7.

[0132] Preferred compounds of formula Ib-3 are selected from the compounds of the formula Ib-3-1:

##STR00027## [0133] in which [0134] n2 on each occurrence identically or differently, preferably identically, is an integer from 1 to 12, preferably 2, 3, 4, 5, or 6, very preferably 3; and [0135] R.sup.S on each occurrence identically or differently, preferably identically, denotes alkyl having 1 to 6 C atoms, very preferably n-butyl.

[0136] Preferred compounds of formula Ib-4 are selected from the compounds of the formula Ib-4-1:

##STR00028## [0137] in which [0138] A and R.sup.S have the meanings defined above, and preferably [0139] A on each occurrence identically or differently, preferably identically, denotes alkylene having 1 to 12, preferably 2, 3, 4, 5, or 6, very preferably 3, C atoms; and [0140] R.sup.S on each occurrence identically or differently, preferably identically, denotes alkyl having 1 to 6 C atoms, very preferably n-butyl; and [0141] n is an integer from 0 to 12, preferably 5, 6, 7, 8, or 9, very preferably 7.

[0142] Specific very preferred compounds of the formula Ib are listed below:

##STR00029## ##STR00030##

[0143] Preferred compounds of the formulae IIA, IIB, IIC and IID are indicated below:

##STR00031## ##STR00032## ##STR00033## ##STR00034## ##STR00035##

##STR00036## ##STR00037## ##STR00038## ##STR00039## ##STR00040## ##STR00041## ##STR00042##

##STR00043## [0144] in which [0145] a denotes 1 or 2; [0146] alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms [0147] alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-6 C atoms; and [0148] (O) denotes an oxygen atom or a single bond.

[0149] Alkenyl and alkenyl* preferably denote CH.sub.2CH, CH.sub.2CHCH.sub.2CH.sub.2, CH.sub.3CHCH, CH.sub.3CH.sub.2CHCH, CH.sub.3(CH.sub.2).sub.2CHCH, CH.sub.3(CH.sub.2).sub.3CHCH or CH.sub.3CHCH(CH.sub.2).sub.2.

[0150] The compounds of the formulae IID-4 and IID-10 are very preferred, where (O) in particular denotes O.

[0151] Very preferred compounds of the formula IID are selected from the following sub-formulae:

##STR00044## ##STR00045## ##STR00046## ##STR00047##

[0152] In a preferred embodiment, the medium comprises one or more compounds of formula IID-10a:

##STR00048## [0153] in which the occurring groups and parameters have the meanings given above under formula IID; and [0154] R.sup.2 denotes

##STR00049## in which r is 0, 1, 2, 3, 4, 5, or 6 and s is 1, 2, or 3.

[0155] Preferred compounds of formula IID-10a are the compounds IID-10a-1 to IID-10a-14.

##STR00050## ##STR00051##

[0156] Particularly preferred mixtures according to the invention comprise one or more compounds of the formulae IIA-2, IIA-8, IIA-10, IIA-16, IIA-18, IIA-40, IIA-41, IIA-42, IIA-43, IIB-2, IIB-10, IIB-16, IIC-1, IID-4, and IID-10.

[0157] Preferred media according to the invention comprise at least one compound of the formula IIC-1,

##STR00052## [0158] in which alkyl and alkyl* have the meanings indicated above.

[0159] In particular, the medium comprises one or more compounds of the formula IIA-2 selected from the following sub-formulae:

##STR00053##

[0160] Alternatively, preferably in addition to the compounds of the formulae IIA-2-1 to IIA-2-5, the medium comprises one or more compounds of the formulae IIA-2a-1 to IIA-2a-5:

##STR00054##

[0161] In particular, the medium comprises one or more compounds of the formula IIA-10 selected from the following sub-formulae:

##STR00055##

[0162] Alternatively, preferably in addition to the compounds of the formulae IIA-10-1 to IIA-10-5, the medium comprises one or more compounds of the formulae IIA-10a-1 to IIA-10a-5:

##STR00056##

[0163] In particular, the medium comprises one or more compounds of the formula IIB-10 selected from the following sub-formulae:

##STR00057##

[0164] Alternatively, preferably in addition to the compounds of the formulae IIB-10-1 to IIB-10-5, the medium comprises one or more compounds of the formulae IIB-10a-1 to IIB-10a-5:

##STR00058##

[0165] Alternatively, preferably in addition to the compounds of the formulae IIC-1, the medium comprises one or more compounds of the formulae IIC-1a-1 and IIC-1a-2:

##STR00059## [0166] in which alkyl denotes straight-chain alkyl having 1 to 7 C atoms, preferably 2 to 5 C atoms, very preferably denotes ethyl.

[0167] The medium according to the invention preferably comprises one or more compounds of formula III:

##STR00060## [0168] in which [0169] R.sup.31 and R.sup.32 each, independently of one another, denote H or an alkyl or alkoxy radical having 1 to 15 C atoms, where one or more CH.sub.2 groups in these radicals may each be replaced, independently of one another, by

##STR00061## -CHCH, CC, CF.sub.2O, OCF.sub.2, O, COO, or OCO in such a way that O atoms are not linked directly to one another, and in which one or more H atoms may be replaced by halogen; [0170] A.sup.31 on each occurrence, independently of one another, denotes [0171] a) 1,4-cyclohexenylene or 1,4-cyclohexylene radical, in which one or two non-adjacent CH.sub.2 groups may be replaced by O or S, [0172] b) a 1,4-phenylene radical, in which one or two CH groups may be replaced by N, or [0173] c) a radical from the group spiro[3.3]heptane-2,6-diyl, 1,4-bicyclo[2.2.2]octylene, naphthalene-2,6-diyl, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, phenanthrene-2,7-diyl, and fluorene-2,7-diyl, where the radicals a), b) and c) may be mono- or polysubstituted by halogen atoms; [0174] n denotes 0, 1, or 2, preferably 0 or 1; [0175] Z.sup.31 on each occurrence independently of one another denotes COO, OCO, CF.sub.2O, OCF.sub.2, CH.sub.2O, OCH.sub.2, CH.sub.2, CH.sub.2CH.sub.2, (CH.sub.2).sub.4, CHCHCH.sub.2O, C.sub.2F.sub.4, CH.sub.2CF.sub.2, CF.sub.2CH.sub.2, CFCF, CHCF, CFCH, CHCH, CC, or a single bond; and [0176] L.sup.31 and L.sup.32 each, independently of one another, denote F, C, CF.sub.3, or CHF.sub.2, preferably H or F, most preferably F; and [0177] W denotes O or S.

[0178] The compounds of formula III are preferably selected from the compounds of the formula III-1 and/or III-2:

##STR00062## [0179] in which [0180] the occurring groups have the same meanings as given under formula III above and preferably [0181] R.sup.31 and R.sup.32 each, independently of one another, are an alkyl, alkenyl, or alkoxy radical having up to 15 C atoms, more preferably one or both of them denote an alkoxy radical; and [0182] L.sup.31 and L.sup.32 each preferably denote F.

[0183] Preferably, the compounds of the formula III-1 are selected from the group of compounds of the formulae III-1-1 to III-1-11, preferably of formula III-1-6:

##STR00063## [0184] in which [0185] alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms; [0186] alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-6 C atoms; [0187] alkoxy and alkoxy* each, independently of one another, denote a straight-chain alkoxy radical having 1-6 C atoms; and [0188] L.sup.31 and L.sup.32 each, independently of one another, denote F or Cl, preferably both F.

[0189] Preferably, the compounds of the formula III-2 are selected from the group of compounds of the formulae III-2-1 to III-2-10, preferably of formula III-2-6:

##STR00064## [0190] in which [0191] alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms; [0192] alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-6 C atoms; [0193] alkoxy and alkoxy* each, independently of one another, denote a straight-chain alkoxy radical having 1-6 C atoms; and [0194] L.sup.31 and L.sup.32 each, independently of one another, denote F or Cl, preferably both F.

[0195] Optionally the medium comprises one or more compounds of the formula IIIA-1 and/or IIIA-2:

##STR00065## [0196] in which L.sup.31 and L.sup.32 have the same meanings as given under formula III, (O) denotes O or a single bond; [0197] R.sup.IIIA denotes alkyl or alkenyl having up to 7 C atoms or a group Cy-C.sub.mH.sub.2m+1: [0198] m and n are, identically or differently, 0, 1, 2, 3, 4, 5, or 6, preferably 1, 2 or, 3, very preferably 1; and [0199] Cy denotes a cycloaliphatic group having 3, 4, or 5 ring atoms, which is optionally substituted with alkyl or alkenyl each having up to 3 C atoms, or with halogen or CN, and preferably denotes cyclopropyl, cyclobutyl, cyclopentyl, cyclopent-1-enyl, cyclopent-2-enyl, or cyclopent-3-enyl.

[0200] The compounds of formula IIIA-1 and/or IIIA-2 are contained in the medium either alternatively or in addition to the compounds of formula III, preferably additionally.

[0201] Very preferred compounds of the formulae IIIA-1 and IIIA-2 are the following:

##STR00066## ##STR00067## [0202] in which alkoxy denotes a straight-chain alkoxy radical having 1-6 C atoms or alternatively (CH.sub.2).sub.nF in which n is 2, 3, 4, or 5, preferably C.sub.2H.sub.4F.

[0203] In a preferred embodiment of the present invention, the medium comprises one or more compounds of formula III-3:

##STR00068## [0204] in which [0205] R.sup.31, R.sup.32 identically or differently, denote H or an alkyl or alkoxy radical having 1 to 15 C atoms, in which one or more CH.sub.2 groups in these radicals are optionally replaced, independently of one another, by CC, CF.sub.2O, OCF.sub.2, CHCH,

##STR00069##

O, COO, or OCO in such a way that O atoms are not linked directly to one another, and in which one or more H atoms may be replaced by halogen.

[0206] The compounds of formula III-3 are preferably selected from the group of compounds of the formulae III-3-1 to III-3-10:

##STR00070## ##STR00071## [0207] in which R.sup.32 denotes alkyl having 1 to 7 C-atoms, preferably ethyl, n-propyl or n-butyl, or alternatively cyclopropylmethyl, cyclobutylmethyl, or cyclopentylmethyl, or alternatively (CH.sub.2).sub.nF in which n is 2, 3, 4, or 5, preferably C.sub.2H.sub.4F.

[0208] In a preferred embodiment of the present invention, the medium comprises one or more compounds of the formulae III-4 to III-6, preferably of formula III-5:

##STR00072## [0209] in which the parameters have the meanings given above, R.sup.31 preferably denotes straight-chain alkyl and R.sup.32 preferably denotes alkoxy, each having 1 to 7 C atoms.

[0210] In a preferred embodiment the medium comprises one or more compounds of the formula III selected from the group of compounds of formulae III-7 to III-9, preferably of formula III-8:

##STR00073## [0211] in which the parameters have the meanings given above, R.sup.31 preferably denotes straight-chain alkyl and R.sup.32 preferably denotes alkoxy each having 1 to 7 C atoms.

[0212] In a preferred embodiment, the medium comprises one or more compounds of the formula IV,

##STR00074## [0213] in which [0214] R.sup.41 denotes an alkyl radical having 1 to 7 C atoms or an alkenyl radical having 2 to 7 C atoms, preferably an n-alkyl radical, particularly preferably having 2, 3, 4, or 5 C atoms; and [0215] R.sup.42 denotes an alkyl radical having 1 to 7 C atoms or an alkoxy radical having 1 to 6 C atoms, both preferably having 2 to 5 C atoms, an alkenyl radical having 2 to 7 C atoms, preferably having 2, 3, or 4 C atoms, more preferably a vinyl radical or a 1-propenyl radical, and in particular a vinyl radical.

[0216] The compounds of the formula IV are preferably selected from the group of the compounds of the formulae IV-1 to IV-4:

##STR00075## [0217] in which [0218] alkyl and alkyl independently of one another, denote alkyl having 1 to 7 C atoms, preferably having 1 to 5 C atoms; [0219] alkenyl denotes an alkenyl radical having 2 to 5 C atoms, preferably having 2 to 4 C atoms, particularly preferably 2 C atoms; [0220] alkenyl denotes an alkenyl radical having 2 to 5 C atoms, preferably having 2 to 4 C atoms, particularly preferably having 2 to 3 C atoms; and [0221] alkoxy denotes alkoxy having 1 to 5 C atoms, preferably having 2 to 4 C atoms.

[0222] The compounds of the formula IV-1 are preferably selected from the group of compounds of the formulae IV-1-1 to IV-1-6:

##STR00076##

[0223] The compounds of the formula IV-2 are preferably selected from the compounds of the formulae IV-2-1 and IV-2-2:

##STR00077##

[0224] The compounds of the formula IV-3 are preferably selected from the group of the compounds of the formulae IV-3-1, IV-3-2, and IV-3-3:

##STR00078##

in which alkyl has the meanings defined above and where the compound of the formula I is excluded from formula IV-3-2.

[0225] The compounds of the formula IV-3-1, IV-3-2 and IV-3-3 are preferably selected from the following compounds:

##STR00079##

[0226] Very preferably, the medium according to the invention comprises a compound of formula IV-4, in particular selected from the compounds of the formulae IV-4-1 to IV-4-3:

##STR00080##

[0227] The liquid-crystalline medium preferably additionally comprises one or more compounds of the formula Iva:

##STR00081## [0228] in which [0229] R.sup.41 and R.sup.42 each, independently of one another, denote a straight-chain alkyl, alkoxy, alkenyl, alkoxyalkyl or alkoxy radical having up to 12 C atoms, and

##STR00082## denotes

##STR00083## and [0230] Z.sup.4 denotes a single bond, CH.sub.2CH.sub.2, CHCH, CF.sub.2O, OCF.sub.2, CH.sub.2O, OCH.sub.2, COO, OCO, C.sub.2F.sub.4, C.sub.4H.sub.8, or CFCF.

[0231] Preferred compounds of the formula IVa are indicated below:

##STR00084## [0232] in which [0233] alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1 to 6 C atoms.

[0234] The medium according to the invention preferably comprises at least one compound of the formula IVa-1 and/or formula IVa-2.

[0235] The proportion of compounds of the formula IVa in the mixture as a whole is preferably less than 5% by weight, very preferably less than 2% by weight.

[0236] Preferably, the medium comprises one or more compounds of formula IVb-1 to IVb-4, more preferably of the compounds of the formulae IVb-1 to IVb-3:

##STR00085## [0237] in which [0238] alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1 to 6 C atoms; and [0239] alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2 to 6 C atoms.

[0240] Of the compounds of the formulae IVb-1 to IVb-3, the compounds of the formula IVb-2 are particularly preferred.

[0241] Particularly preferred biphenyls are

##STR00086## [0242] in which alkyl* denotes an alkyl radical having 1 to 6 C atoms and preferably denotes n-propyl. The medium according to the invention particularly preferably comprises one or more compounds of the formulae IVb-1-1 and/or IVb-2-3.

[0243] In a preferred embodiment, the medium according to the invention comprises one or more compounds of formula V:

##STR00087## [0244] in which [0245] R.sup.51, R.sup.52 denote alkyl having 1 to 7 C atoms, alkoxy having 1 to 7 C atoms, or alkoxyalkyl, alkenyl, or alkenyloxy having 2 to 7 C atoms;

##STR00088## [0246] identically or differently, denote

##STR00089## [0247] Z.sup.51, Z.sup.52 each, independently of one another, denote CH.sub.2CH.sub.2, CH.sub.2O, CHCH, CC, COO, or a single bond; and [0248] n is 1 or 2, where the compounds of the formula CL are excluded.

[0249] The compounds of formula V are preferably selected from the compounds of the formulae V-1, V-2 and V-3:

##STR00090## [0250] in which the groups occurring have the meanings given above for formula V.

[0251] The compounds of formula V-1 are preferably selected from the compounds of the formulae V-1-1 to V-1-8; [0252] the compounds of formula V-2 are preferably selected from the compounds of the formulae V-2-1 to V-2-4; and [0253] the compounds of formula V-3 are preferably selected from the compounds of the formulae V-3-1 to V-3-7:

##STR00091## ##STR00092## [0254] in which [0255] R.sup.51 and R.sup.52 have the meanings indicated for formula V above; and [0256] R.sup.51 and R.sup.52 preferably each, independently of one another, denote straight-chain alkyl having 1 to 7 C atoms or alkenyl having 2 to 7 C atoms.

[0257] Very preferred compounds of the formula V-2-1 are selected from the compounds of the formulae V-2-1a to V-2-1g

##STR00093##

[0258] Very preferred compounds of the formula V-2-2 are selected from the compounds of the formulae V-2-2a to V-2-2i:

##STR00094##

[0259] Preferably, the medium according to the invention comprises one or more compounds of the formula CL:

##STR00095## [0260] in which [0261] R.sup.L denotes H, a straight-chain or branched alkyl or alkoxy radical having 1 to 15 C atoms, or a straight-chain or branched alkenyl radical having 2 to 15 C atoms, where one or more CH.sub.2 groups in these radicals may each be replaced, independently of one another, by

##STR00096## CC, CF.sub.2O, OCF.sub.2, CHCH, O, COO, or OCO in such a way that O atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by halogen; [0262] X.sup.L denotes F, Cl, CN, CHF.sub.2, CF.sub.3, OCF.sub.3, or, identically or differently, has one of the meanings of R.sup.L; and [0263] Y.sup.L denotes H, F, Cl or CH.sub.3.

[0264] The compounds of formula CL are preferably selected form the group of compounds of the formulae CL-1, CL-2 and CL-3:

##STR00097## [0265] in which [0266] R.sup.L1 and R.sup.L2, identically or differently, have the meanings given above for formula I and preferably denote alkyl or alkenyl having 1 to 7 C atoms or 2 to 7 C atoms, respectively, in which a CH.sub.2 group may be replaced by cyclopropane-1,2-diyl, and R.sup.L2 alternatively denotes alkoxy having 1 to 5 C atoms.

[0267] Very preferred compounds of the formula CL are selected from the compounds of the formulae CL-3-1 to CL-3-12:

##STR00098## ##STR00099##

[0268] In a particularly preferred embodiment, the medium according to the invention comprises the compound CL-3-1 or CLP-3-3.

[0269] In a preferred embodiment of the present invention the medium additionally comprises one or more compounds of the formula VI:

##STR00100## [0270] in which [0271] R.sup.61 and R.sup.62 denote H, F, straight-chain alkyl or alkoxy having 1 to 15 C atoms, straight-chain alkenyl or alkenyloxy having 2 to 15 C atoms or branched alkyl, alkoxy, alkenyl, alkenyloxy each having 3 to 15 C atoms, where one or more CH.sub.2 groups in these radicals may each be replaced, independently of one another, by

##STR00101## CC, [0272] CF.sub.2O, OCF.sub.2, CHCH, O, COO, or OCO in such a way that O atoms are not linked directly to one another, and in which one or more H atoms may be replaced by halogen; [0273] X.sup.61, X.sup.62, X.sup.63, X.sup.64, X.sup.65, and X.sup.66 identically or differently, denote H or F, preferably at least one of X.sup.61, X.sup.62, X.sup.63, X.sup.64, X.sup.65, and X.sup.66 denotes F, more preferably at least two of X.sup.61, X.sup.62, X.sup.63, X.sup.64, X.sup.65, and X.sup.66 denote F; and [0274] Z.sup.61 and Z.sup.62 identically or differently, denote CH.sub.2CH.sub.2 or a single bond.

[0275] The compounds of the formula VI are preferably selected from the formulae VI-1 and VI-2:

##STR00102## [0276] in which the occurring groups have the meanings given for formula VI.

[0277] The compounds of the formula VI-1 are preferably selected from the formulae VI-1-1 to VI-1-21, very preferably of the formula VI-1-4:

##STR00103## ##STR00104## ##STR00105## [0278] in which [0279] R.sup.6 denotes a straight-chain alkyl or alkoxy radical having 1 to 6 C atoms; [0280] (O) denotes O or a single bond; [0281] m is 0, 1, 2, 3, 4, 5, or 6; and [0282] n is 0, 1, 2, 3, or 4.

[0283] R preferably denotes methyl, ethyl, propyl, butyl, pentyl, hexyl, methoxy, ethoxy, propoxy, butoxy, or pentoxy.

[0284] In formula VI-1-22, R.sup.6 preferably denotes n-propyl.

[0285] In the compounds of the formula VI-1-4, (O) preferably denotes O.

[0286] The compounds of the formula VI-2 are preferably selected from the formulae VI-2-1 to VI-2-15, very preferably of the formula VI-2-1:

##STR00106## ##STR00107## [0287] in which R.sup.6 denotes a straight-chain alkyl or alkoxy radical having 1 to 6 C atoms; [0288] (O) denotes O or a single bond; [0289] m is 0, 1, 2, 3, 4, 5, or 6; and [0290] n is 0, 1, 2, 3, or 4.

[0291] R preferably denotes methyl, ethyl, propyl, butyl, pentyl, hexyl, methoxy, ethoxy, propoxy, butoxy, or pentoxy.

[0292] In a preferred embodiment of the present invention the medium additionally comprises one or more compounds of the formulae VII-1 to VII-9:

##STR00108## [0293] in which [0294] R.sup.7 denotes a straight-chain alkyl or alkoxy radical having 1 to 6 C atoms, or a straight-chain alkenyl radical having 2 to 6 C atoms; and [0295] w is an integer from 1 to 6.

[0296] Preferably, the medium according to the invention comprises one or more compounds of the formula VIII:

##STR00109## [0297] in which [0298] R.sup.81 and R.sup.82 identically or differently, denote H, halogen, CN, SCN, straight-chain alkyl or alkoxy having 1 to 15 C atoms, straight-chain alkenyl or alkenyloxy having 2 to 15 C atoms, or branched alkyl, alkoxy, alkenyl or alkenyloxy having 3 to 15 C atoms, where one or more CH.sub.2 groups in these radicals may each be replaced, independently of one another, by

##STR00110## CC, CF.sub.2O, OCF.sub.2, CHCH, by O, COO, or OCO in such a way that O atoms are not linked directly to one another, and in which one or more H atoms may be replaced by halogen; [0299] A.sup.0, A.sup.81, and A.sup.82 each, independently of one another, denote phenylene-1,4-diyl, in which one or two CH groups may be replaced by N and one or more H atoms may be replaced by halogen, CN, CH.sub.3, CHF.sub.2, CH.sub.2F, CF.sub.3, OCH.sub.3, OCHF.sub.2 OCF.sub.3, or cyclohexane-1,4-diyl, in which one or two non-adjacent CH.sub.2 groups may be replaced, independently of one another, by O and/or S, and one or more H atoms may be replaced by F, cyclohexene-1,4-diyl, bicyclo[1.1.1]pentane-1,3-diyl, bicyclo[2.2.2]octane-1,4-diyl, spiro[3.3]heptane-2,6-diyl, tetrahydropyran-2,5-diyl, or 1,3-dioxane-2,5-diyl; [0300] Z.sup.81 and Z.sup.82 each, independently of one another, denote CF.sub.2O, OCF.sub.2, CH.sub.2O, OCH.sub.2, COO, OCO, C.sub.2H.sub.4, C.sub.2F.sub.4, CF.sub.2CH.sub.2, CH.sub.2CF.sub.2, CFHCFH, CFHCH.sub.2, CH.sub.2CFH, CF.sub.2CFH, CFHCF.sub.2, CHCH, CFCH, CHCF, [0301] CFCF, CC, or a single bond; [0302] n denotes 0, 1, 2, or 3, preferably 0, 1, or 2, very preferably 0 or 1, particularly preferably 0; and [0303] m denotes 0, 1, 2, or 3, preferably 0, 1, or 2, very preferably 1 or 2, in particular 1.

[0304] A.sup.81 and A.sup.82 in formula I preferably denote phenylene-1,4-diyl, which may also be mono- or polysubstituted by F, furthermore cyclohexane-1,4-diyl, cyclohexenylene-1,4-diyl, tetrahydropyran-2,5-diyl, or 1,3-dioxane-2,5-diyl, very preferably phenylene-1,4-diyl which may also be mono- or polysubstituted by F, or cyclohexane-1,4-diyl.

[0305] Z.sup.81 and Z.sup.82 in formula VIII preferably denote CF.sub.2O, OCF.sub.2 or a single bond, very preferably a single bond.

[0306] A.sup.81 and A.sup.82 in formula VIII particularly preferably denote

##STR00111## [0307] in which L denotes halogen, CF.sub.3, or CN, preferably F.

[0308] Preference is furthermore given to compounds of the formula VIII in which R.sup.81 and R.sup.82 each, independently of one another, denote H, F, or alkyl, alkoxy, alkenyl, or alkynyl having 1 to 8, preferably 1 to 5, C atoms, each of which is optionally substituted by halogen, in particular by F.

[0309] R.sup.81 and R.sup.82 preferably denote H, optionally fluorinated alkyl or alkoxy having 1 to 7 C atoms, optionally fluorinated alkenyl or alkynyl having 2 to 7 C atoms, optionally fluorinated cycloalkyl having 3 to 12 C atoms.

[0310] Preferably, at least one of R.sup.81 and R.sup.82 is not H, particularly preferably both of R.sup.81 and R.sup.82 are not H. R.sup.81 is very particularly preferably alkyl. R.sup.82 is furthermore preferably H, alkyl or fluorine. Very particularly preferably, R.sup.81 is alkyl and R.sup.82 is H or alkyl. R.sup.81, R.sup.82 each, independently of one another, very particularly preferably denote unbranched alkyl having 1 to 5 C atoms. If R.sup.81 and R.sup.82 denote substituted alkyl, alkoxy, alkenyl, or alkynyl, the total number of C atoms in the two groups R.sup.81 and R.sup.82 is preferably less than 10.

[0311] Preferred compounds of the formula VIII are selected from the compounds of the formula VIIIa:

##STR00112## [0312] in which R.sup.1 and R.sup.2, identically or differently, denote straight-chain alkyl having 1 to 15 C atoms, straight-chain alkenyl having 2 to 15 C atoms, or branched alkyl or alkenyl having 3 to 15 C atoms, where one or more CH.sub.2 groups in these radicals may each be replaced, independently of one another, by

##STR00113## and in which one or more H atoms may be replaced by fluorine, preferably both of R.sup.1 and R.sup.2 denote straight-chain alkyl having 1 to 6 C atoms.

[0313] Very preferred compounds of the formula VIIIa are selected from the compounds of the formulae VIIIa-1 to VIIIa-35:

##STR00114## ##STR00115## ##STR00116## ##STR00117## ##STR00118## [0314] in which v is an integer from 1 to 6.

[0315] Further preferred compounds of the formula VIII are selected from the following sub-formulae:

##STR00119## [0316] in which [0317] R.sup.81, R.sup.82 and L have the meanings indicated above; [0318] L preferably denotes F; and [0319] r, s, and t independently are 0, 1, 2, 3, or 4.

[0320] r preferably is 1 or 2, very preferably 2, and s and t independently are preferably 0 or 1, very preferably 0. R.sup.81 and R.sup.82 in particular independently denote n-alkyl having 1 to 5 C atoms.

[0321] In a first very preferred embodiment, the compounds of the formulae VIII-1 to VIII-6 are selected from the compounds of the formula VIII-1a to VIII-6a, in particular of the formula VIII-3a:

##STR00120## [0322] in which R.sup.81, R.sup.82, r, and s have the meanings defined above.

[0323] In a second very preferred embodiment, the compounds of the formulae VIII-1 to VIII-6 are selected from the compounds of the formula VIII-1 b to VIII-6b, in particular of the formula I3-b:

##STR00121## [0324] in which R.sup.81, R.sup.82, L, r and s have the meanings defined above.

[0325] In a third very preferred embodiment, the compounds of the formulae VIII-1 to VIII-6 are selected from the compounds of the formula VIII-1c to VIII-6c, in particular of the formula I3-c:

##STR00122## [0326] in which R.sup.81, R.sup.82, L, r, and s have the meanings defined above.

[0327] In a fourth very preferred embodiment, the compounds of the formulae VIII-1 to VIII-6 are selected from the compounds of the formula VIII-1d to VIII-6d, in particular of the formula VIII-3d:

##STR00123## [0328] in which R.sup.81, R.sup.82, L, r and s have the meanings defined above.

[0329] In a particularly preferred embodiment, the medium according to the invention comprises one or more compounds selected from the group of the formulae VIII-1a to VIII-6a and one or more compounds selected from the group of the formulae VIII-1 b to VIII-6b.

[0330] Very particularly preferably the medium comprises one or more compounds selected from the group of compounds of the formulae VIII-3a, VIII-3b, VIII-3c, and VIII-3d:

##STR00124## [0331] in which R.sup.81, R.sup.82, L, and r have the meanings defined above and preferably r is 0.

[0332] Most preferred compounds of formula I include, in particular, one or more of the following:

##STR00125## ##STR00126## ##STR00127##

[0333] Alternatively, or additionally, the following compounds of formula I can be used:

##STR00128## ##STR00129## ##STR00130## ##STR00131##

[0334] In a preferred embodiment, the medium comprises one or more compounds of the formula IX:

##STR00132## [0335] in which [0336] R.sup.1 and R.sup.2 identically or differently, denote H, halogen, straight-chain alkyl or alkoxy having 1 to 15 C atoms, straight-chain alkenyl or alkenyloxy having 2 to 15 C atoms, or branched alkyl, alkoxy, alkenyl or alkenyloxy each having 3 to 15 C atoms, where one or more CH.sub.2 groups in these radicals may each be replaced, independently of one another, by

##STR00133## CC, CF.sub.2O, OCF.sub.2, CHCH, by O, COO, or OCO in such a way that O atoms are not linked directly to one another, and in which one or more H atoms may be replaced by halogen; [0337] L.sup.11 and L.sup.12 each, independently of one another, denote F, Cl, CF.sub.3, or CHF.sub.2; [0338] L.sup.13 and L.sup.14 each, independently of one another, denote H, F, Cl, CF.sub.3, or CHF.sub.2; [0339] Y.sup.1 denotes H, F, Cl, CF.sub.3, CHF.sub.2, or CH.sub.3, preferably H or CH.sub.3; and [0340] n is 0 or 1.

[0341] Preference is given to LC media comprising the compounds of formula IX in which n is 0, Y denotes H or CH.sub.3, more preferably H, and L.sup.11 and L.sup.12 denote F.

[0342] Very preferred compounds of the formula IX are selected from the compounds of the formulae IX-1 to IX-35:

##STR00134## ##STR00135## ##STR00136## ##STR00137## ##STR00138##

[0343] In a preferred embodiment of the present invention the medium comprises one or more compounds of the formula X:

##STR00139## [0344] in which

##STR00140## denotes

##STR00141## denotes

##STR00142## [0345] R.sup.X denote a straight-chain or branched alkyl or alkoxy radical having 1 to 15 C atoms, where one or more CH.sub.2 groups in these radicals may each be replaced, independently of one another, by

##STR00143## CC, CF.sub.2O, OCF.sub.2, CHCH, O, COO, or OCO in such a way that O atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by halogen, preferably by F; [0346] X.sup.X denotes F, Cl, CN, SF.sub.5, SCN, NCS, a halogenated alkyl radical or a halogenated alkoxy radical each having 1 to 6 C atoms, or a halogenated alkenyl radical or a halogenated alkenyloxy radical each having 2 to 6 C atoms; and [0347] Z.sup.X denotes C.sub.2H.sub.4, CH.sub.2O, CF.sub.2O, CHCH, or a single bond.

[0348] In the compounds of formula X, R.sup.X denotes preferably alkyl with 1 to 6 C atoms or alkenyl with 2 to 6 C atoms which are preferably straight-chain.

[0349] In the compounds of formula X, X.sup.X is preferably F, C, a mono- or polyfluorinated alkyl or alkoxy radical having 1, 2, or 3 C atoms, or a mono- or polyfluorinated alkenyl radical having 2 or 3 C atoms. X.sup.X is more preferably F, C, CF.sub.3, CHF.sub.2, OCF.sub.3, OCHF.sub.2, OCFHCF.sub.3, OCFHCHF.sub.2, OCFHCHF.sub.2, OCF.sub.2CH.sub.3, OCF.sub.2CHF.sub.2, OCF.sub.2CHF.sub.2, OCF.sub.2CF.sub.2CHF.sub.2, OCF.sub.2CF.sub.2CHF.sub.2, OCFHCF.sub.2CF.sub.3, OCFHCF.sub.2CHF.sub.2, OCF.sub.2CF.sub.2CF.sub.3, OCF.sub.2CF.sub.2CClF.sub.2, OCClFCF.sub.2CF.sub.3, OCHCF.sub.2, or CHCF.sub.2, very preferably F, OCF.sub.3, furthermore CF.sub.3, OCFCF.sub.2, OCHF.sub.2, or OCHCF.sub.2, very particularly preferably F, OCF.sub.3, or CF.sub.3, most preferably F.

[0350] Preferred compounds of formula X are selected from the following sub-formulae:

##STR00144## [0351] in which R.sup.X has one of the meanings given in formula X and preferably denotes straight-chain alkyl having 1-6 C atoms, very preferably ethyl, propyl, or butyl, or straight-chain alkenyl with 2 to 6 C atoms very preferably vinyl or 1-propenyl, most preferably vinyl, and X.sup.X has one of the meanings given in formula X and preferably denotes F, CF.sub.3 or OCF.sub.3, very preferably F.

[0352] Very preferred compounds of formula X are selected from the following sub-formulae:

##STR00145## ##STR00146## ##STR00147## ##STR00148##

[0353] Preferably the LC medium contains one or more compounds selected from the group consisting of the formulae X1-1, X1-3, X2-1, and X2-3.

[0354] Further preferred embodiments are listed below: [0355] a) Liquid-crystalline medium comprising at least one compound of the formulae Z-1 to Z-8, preferably of the formulae Z-2, Z-4, and Z-6, very preferably Z-4:

##STR00149## [0356] in which [0357] R.sup.Z has the meaning of R.sup.2A indicated above and preferably denotes alkyl having 1 to 7 C atoms or alkenyl having 2 to 7 C atoms; and [0358] (O) denotes O or a single bond and alkyl denotes alkyl having 1 to 7 C atoms. [0359] b) Preferred liquid-crystalline media according to the invention comprise one or more substances which contain a tetrahydronaphthyl or naphthyl unit, such as, for example, the compounds of the formulae N-1 to N-5,

##STR00150## [0360] in which [0361] R.sup.1N and R.sup.2N each, independently of one another, have the meanings indicated for R.sup.2A, preferably denote straight-chain alkyl, straight-chain alkoxy or straight-chain alkenyl; and [0362] Z.sup.1 and Z.sup.2 each, independently of one another, denote C.sub.2H.sub.4, CHCH, (CH.sub.2).sub.4, (CH.sub.2).sub.3O, O(CH.sub.2).sub.3, CHC HCH.sub.2CH.sub.2, CH.sub.2CH.sub.2CHCH, CH.sub.2O, OCH.sub.2, COO, OCO, C.sub.2F.sub.4, CFCF, CFCH, CHCF, CF.sub.2O, OCF.sub.2, CH.sub.2, or a single bond. [0363] c) Preferred mixtures comprise one or more compounds selected from the group of the difluorodibenzochroman compounds of the formula BC, chromans of the formula CR, and fluorinated phenanthrenes of the formulae PH-1 and PH-2:

##STR00151## [0364] in which R.sup.B1, R.sup.B2, R.sup.CR1, R.sup.CR2, R.sup.P1, R.sup.P2 each, independently of one another, have the meaning of R.sup.31 of formula III, preferably alkyl or alkoxy having 1 to 6 C atoms, and [0365] c is 0, 1 or 2.

[0366] Particularly preferred compounds of the formulae BC, CR and PH-1 are the compounds BC-1 to BC-7, CR-1 to CR-5, and BP-1 to BP-7:

##STR00152## ##STR00153## [0367] in which [0368] alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1 to 6 C atoms; and [0369] alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2 to 6 C atoms.

[0370] More preference is given to mixtures comprising one, two, or three compounds of the formula BC-2, BC-3, BP-2, and/or BP-3, very preferably BP-2 and/or BP-3, in particular BP-3. [0371] d) Preferred mixtures comprise one or more indane compounds of the formula In:

##STR00154## [0372] in which [0373] R.sup.11, R.sup.12, and R.sup.13 each, independently of one another, denote a straight-chain alkyl, alkoxy, alkoxyalkyl, or alkenyl radical having 1 to 6 C atoms; [0374] R.sup.12 and R.sup.13 alternatively denote halogen, preferably F;

##STR00155## denotes

##STR00156## [0375] and [0376] i denotes 0, 1 or 2.

[0377] Preferred compounds of the formula In are the compounds of the formulae In-1 to In-16 indicated below:

##STR00157## ##STR00158##

[0378] Particular preference is given to the compounds of the formulae In-1, In-2, In-3, and In-4. [0379] e) Preferred mixtures additionally comprise one or more compounds of the formulae L-1 to L-11:

##STR00159## ##STR00160## [0380] in which [0381] R, R.sup.1, and R.sup.2 each, independently of one another, have the meanings indicated for R.sup.2A in formula IIA above, and alkyl denotes an alkyl radical having 1 to 6 C atoms; and [0382] s denotes 1 or 2.

[0383] The compounds of the formulae L-1 to L-9 are preferably employed in concentrations of 5 to 15% by weight, in particular 5 to 12% by weight, and very particularly preferably 8 to 10% by weight. [0384] f) Preferred mixtures additionally comprise one or more compounds of formula IIA-Y:

##STR00161## [0385] in which [0386] R.sup.11 and R.sup.12 have one of the meanings given for R.sup.2A in formula IIA above; and [0387] L.sup.1 and L.sup.2 identically or differently, denote F or Cl.

[0388] Preferred compounds of the formula IIA-Y are selected from the group consisting of the following sub-formulae:

##STR00162## [0389] in which, [0390] Alkyl and Alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms; [0391] Alkoxy denotes a straight-chain alkoxy radical having 1-6 C atoms; [0392] Alkenyl and Alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-6 C atoms; and [0393] O denotes an oxygen atom or a single bond.

[0394] Alkenyl and Alkenyl* preferably denote CH.sub.2CH, CH.sub.2CHCH.sub.2CH.sub.2, CH.sub.3CHCH, CH.sub.3CH.sub.2CHCH, CH.sub.3(CH.sub.2).sub.2CHCH, CH.sub.3(CH.sub.2).sub.3CHCH, or CH.sub.3CHCH(CH.sub.2).sub.2.

[0395] Particularly preferred compounds of the formula IIA-Y are selected from the group consisting of following sub-formulae:

##STR00163## [0396] in which Alkoxy and Alkoxy* have the meanings defined above and preferably denote methoxy, ethoxy, n-propyloxy, n-butyloxy, or n-pentyloxy, very preferably both butoxy.

[0397] Preferably, the medium according to the invention comprises a compound selected from the group of compounds of the formulae S-1 to S-15:

##STR00164## [0398] in which n=0 or 1

##STR00165## [0399] in which n=1, 2, 3, 4, 5, 6, or 7, preferably n=1 or 7, very [0400] preferably 7,

##STR00166## ##STR00167## [0401] in which [0402] R.sup.ST denotes H, an alkyl radical having 1 to 15 C atoms, or an alkoxy radical having 1 to 15 C atoms, where, in addition, one or more CH.sub.2 groups in these radicals may each be replaced, independently of one another by CC, CF.sub.2O, OCF.sub.2, CHOCH,

##STR00168## COO, or OCO in such a way that O atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by halogen;

##STR00169## on each occurrence, identically or differently, denotes

##STR00170## [0403] p denotes 0, 1, or 2; and [0404] q denotes 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10.

[0405] The compounds of the formulae S-1 to S-15 are preferably each present in the liquid-crystal mixtures according to the invention in amounts of 0.005-0.5%, based on the mixture.

[0406] If the mixtures according to the invention comprise two or more compounds from the group of the compounds of the formulae S-1 to S-15, the concentration correspondingly increases to 0.01-1% in the case of two compounds, based on the mixtures.

[0407] However, the total proportion of the compounds of the formulae ST and S-1 to S-15, based on the mixture according to the invention, should not exceed 2%.

[0408] The liquid crystal medium according to the invention, herein also referred to as liquid crystal host mixture, is suitable for the use in polymer stabilized displays. To this end, the medium according to the invention optionally comprises one or more polymerizable compounds of formula P:

P-Sp-A.sup.1-(Z.sup.1-A.sup.2).sub.z-RP [0409] in which independently of each other and on each occurrence identically or differently, [0410] P denotes a polymerizable group; [0411] Sp denotes a spacer group or a single bond; [0412] A.sup.1, A.sup.2 denote an aromatic, heteroaromatic, alicyclic, or heterocyclic group, preferably having 4 to 25 ring atoms, which may also contain fused rings, and which is unsubstituted, monosubstituted, or polysubstituted by L; [0413] Z.sup.1 denotes O, S, CO, COO, OCO, OCOO, OCH.sub.2, CH.sub.2O, SCH.sub.2, CH.sub.2S, CF.sub.2O, OCF.sub.2, CF.sub.2S, SCF.sub.2, (CH.sub.2).sub.n1, CF.sub.2CH.sub.2, CH.sub.2CF.sub.2, (CF.sub.2).sub.n1, CHCH, CFCF, CHCF, CFCH, CC, CHCHCOO, OCOCHCH, CH.sub.2CH.sub.2COO, OCOCH.sub.2CH.sub.2, CR.sup.0R.sup.00, or a single bond; [0414] R.sup.0, R.sup.0 denote H or alkyl having 1 to 12 C atoms; [0415] R denotes H, L, or P-Sp-; [0416] L denotes F, Cl, CN, P-Sp-, straight-chain alkyl having 1 to 25 C atoms, or branched or cyclic alkyl having 3 to 25 C atoms, wherein one or more non-adjacent CH.sub.2-groups are optionally replaced by O, S, CO, COO, OCO, or OCOO in such a manner that O- and/or S-atoms are not directly connected with each other, and wherein one or more H atoms are each optionally replaced by P-Sp-, F, or Cl; [0417] z is 0, 1, 2, or 3; and [0418] n1 is 1, 2, 3, or 4.

[0419] The term reliability as used herein means the quality of the performance of the display during time and with different stress loads, such as light load, temperature, humidity, voltage, and comprises display effects such as image sticking (area and line image sticking), mura, yogore, etc., which are known to the skilled person in the field of LC displays. As a standard parameter for categorizing the reliability, usually the voltage holding ratio (VHR) value is used, which is a measure for maintaining a constant electrical voltage in a test display. Among other factors, a high VHR is a prerequisite for a high reliability of the LC medium.

[0420] Unless indicated otherwise, the term PSA is used hereinafter when referring to displays of the polymer-sustained alignment type in general, and the term PS is used when referring to specific display modes, like PS-VA, PS-TN, and the like.

[0421] As used herein, the terms active layer and switchable layer mean a layer in an electro-optical display, for example an LC display, that comprises one or more molecules having structural and optical anisotropy, like for example LC molecules, which change their orientation upon an external stimulus like an electric or magnetic field, resulting in a change of the transmission of the layer for polarized or unpolarized light.

[0422] As used herein, the terms tilt and tilt angle will be understood to mean a tilted alignment of the LC molecules of an LC medium relative to the surfaces of the cell in an LC display (here preferably a PSA display). The tilt angle here denotes the average angle (<90) between the longitudinal molecular axes of the LC molecules (LC director) and the surface of the plane-parallel outer plates which form the LC cell. A low value for the tilt angle (i.e., a large deviation from the 90 angle) corresponds to a large tilt here. A suitable method for measurement of the tilt angle is given in the examples. Unless indicated otherwise, tilt angle values disclosed above and below relate to this measurement method.

[0423] As used herein, the terms reactive mesogen and RM will be understood to mean a compound containing a mesogenic or liquid crystalline skeleton, and one or more functional groups attached thereto which are suitable for polymerization and are also referred to as polymerizable group or P.

[0424] Unless stated otherwise, the term polymerizable compound as used herein will be understood to mean a polymerizable monomeric compound.

[0425] As used herein, the term low-molecular-weight compound will be understood to mean to a compound that is monomeric and/or is not prepared by a polymerization reaction, as opposed to a polymeric compound or a polymer.

[0426] As used herein, the term unpolymerizable compound will be understood to mean a compound that does not contain a functional group that is suitable for polymerization under the conditions usually applied for the polymerization of the RMs.

[0427] The term mesogenic group as used herein is known to the person skilled in the art and described in the literature, and means a group which, due to the anisotropy of its attracting and repelling interactions, essentially contributes to causing a liquid-crystal (LC) phase in low-molecular-weight or polymeric substances. Compounds containing mesogenic groups (mesogenic compounds) do not necessarily have to have an LC phase themselves. It is also possible for mesogenic compounds to exhibit LC phase behavior only after mixing with other compounds and/or after polymerization. Typical mesogenic groups are, for example, rigid rod- or disc-shaped units. An overview of the terms and definitions used in connection with mesogenic, or LC compounds is given in Pure Appl. Chem. 2001, 73(5), 888 and C. Tschierske, G. Pelzl, S. Diele, Angew. Chem. 2004, 116, 6340-6368.

[0428] As used herein, the terms optically active and chiral are synonyms for materials that are able to induce a helical pitch in a nematic host material, also referred to as chiral dopants.

[0429] The term spacer group, above and below also referred to as Sp, as used herein is known to the person skilled in the art and is described in the literature, see, for example, Pure Appl. Chem. 2001, 73(5), 888 and C. Tschierske, G. Pelzl, S. Diele, Angew. Chem. 2004, 116, 6340-6368. As used herein, the terms spacer group or spacer mean a flexible group, for example an alkylene group, which connects a mesogenic group and a polymerizable group(s) in a polymerizable mesogenic compound.

[0430] Likewise, in the compounds of formula Ia and Ib, a spacer group connects a central hydrocarbon group with a photoactive, stabilizing hindered amine functional group.

[0431] Above and below,

##STR00171##

denotes a trans-1,4-cyclohexylene ring.

[0432] In a group

##STR00172##

the single bond shown between the two ring atoms can be attached to any free position of the benzene ring.

[0433] Above and below organic group denotes a carbon or hydrocarbon group.

[0434] Carbon group denotes a mono- or polyvalent organic group containing at least one carbon atom, where this either contains no further atoms (such as, for example, CC) or optionally contains one or more further atoms, such as, for example, N, O, S, B, P, Si, Se, As, Te, or Ge (for example carbonyl, etc.). The term hydrocarbon group denotes a carbon group which additionally contains one or more H atoms and optionally one or more heteroatoms, such as, for example, N, O, S, B, P, Si, Se, As, Te, or Ge.

[0435] Halogen denotes F, Cl, Br, or I, preferably F or Cl.

[0436] CO, C(O) and C(O) denote a carbonyl group, i.e.,

##STR00173##

[0437] A carbon or hydrocarbon group can be a saturated or unsaturated group. Unsaturated groups are, for example, aryl, alkenyl, or alkynyl groups. A carbon or hydrocarbon radical having more than 3 C atoms can be straight-chain, branched, and/or cyclic, and may also contain spiro links or condensed rings.

[0438] The terms alkyl, aryl, heteroaryl, etc., also encompass polyvalent groups, for example alkylene, arylene, heteroarylene, etc.

[0439] The term aryl denotes an aromatic carbon group, or a group derived therefrom. The term heteroaryl denotes aryl as defined above, containing one or more heteroatoms, preferably selected from N, O, S, Se, Te, Si, and Ge.

[0440] Preferred carbon and hydrocarbon groups are optionally substituted, straight-chain, branched, or cyclic alkyl, alkenyl, alkynyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy, and/or alkoxycarbonyloxy having 1 to 40 or 3 to 40, preferably 1 to 20 or 3 to 20, very preferably 1 to 12 or 3 to 12, C atoms, optionally substituted aryl or aryloxy having 5 to 30, preferably 6 to 25, C atoms, or optionally substituted alkylaryl, arylalkyl, alkylaryloxy, arylalkyloxy, arylcarbonyl, aryloxycarbonyl, arylcarbonyloxy, and/or aryloxycarbonyloxy having 5 to 30, preferably 6 to 25, C atoms, wherein one or more C atoms may also be replaced by hetero atoms, preferably selected from N, O, S, Se, Te, Si, and Ge.

[0441] Further preferred carbon and hydrocarbon groups are C.sub.1-C.sub.20 alkyl, C.sub.2-C.sub.20 alkenyl, C.sub.2-C.sub.20 alkynyl, C.sub.3-C.sub.20 allyl, C.sub.4-C.sub.20 alkyldienyl, C.sub.4-C.sub.20 polyenyl, C.sub.6-C.sub.20 cycloalkyl, C.sub.4-C.sub.15 cycloalkenyl, C.sub.6-C.sub.30 aryl, C.sub.6-C.sub.30 alkylaryl, C.sub.6-C.sub.30 arylalkyl, C.sub.6-C.sub.30 alkylaryloxy, C.sub.6-C.sub.30 aryl-alkyloxy, C.sub.2-C.sub.30 heteroaryl, and/or C.sub.2-C.sub.30 heteroaryloxy.

[0442] Particular preference is given to C.sub.1-C.sub.12 alkyl, C.sub.2-C.sub.12 alkenyl, C.sub.2-C.sub.12 alkynyl, C.sub.6-C.sub.25 aryl, and C.sub.2-C.sub.25 heteroaryl.

[0443] Further preferred carbon and hydrocarbon groups are straight-chain alkyl having 1 to 20, preferably 1 to 12, C atoms, or branched or cyclic alkyl having 3 to 20, preferably 3 to 12, C atoms, which are unsubstituted, monosubstituted, or polysubstituted by F, Cl, Br, I, or CN and in which one or more non-adjacent CH.sub.2 groups may each be replaced, independently of one another, by C(R.sup.x)C(R.sup.x), CC, N(R.sup.x), O, S, CO, COO, OCO, or OCOO in such a way that O and/or S atoms are not linked directly to one another.

[0444] R.sup.x preferably denotes H, F, Cl, CN, a straight-chain alkyl chain having 1 to 25 C atoms, or a branched or cyclic alkyl chain having 3 to 25 C atoms, in which, in addition, one or more non-adjacent C atoms may be replaced by O, S, CO, COO, OCO, or OCOO, and in which one or more H atoms may be replaced by F or C, or denotes an optionally substituted aryl or aryloxy group with 6 to 30 C atoms, or an optionally substituted heteroaryl or heteroaryloxy group with 2 to 30 C atoms.

[0445] Preferred alkyl groups are, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, 2-methylbutyl, n-pentyl, s-pentyl, cyclopentyl, n-hexyl, cyclohexyl, 2-ethylhexyl, n-heptyl, cycloheptyl, n-octyl, cyclooctyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, dodecanyl, trifluoromethyl, perfluoro-n-butyl, 2,2,2-trifluoroethyl, perfluorooctyl, perfluorohexyl, etc.

[0446] Preferred alkenyl groups are, for example, ethenyl, propenyl, butenyl, pentenyl, cyclopentenyl, hexenyl, cyclohexenyl, heptenyl, cycloheptenyl, octenyl, cyclooctenyl, etc.

[0447] Preferred alkynyl groups are, for example, ethynyl, propynyl, butynyl, pentynyl, hexynyl, octynyl, etc.

[0448] Preferred alkoxy groups are, for example, methoxy, ethoxy, 2-methoxyethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, s-butoxy, t-butoxy, 2-methylbutoxy, n-pentoxy, n-hexoxy, n-heptoxy, n-octoxy, n-nonoxy, n-decoxy, n-undecoxy, n-dodecoxy, etc.

[0449] Preferred amino groups are, for example, dimethylamino, methylamino, methylphenylamino, phenylamino, etc.

[0450] Aryl and heteroaryl groups can be monocyclic or polycyclic, i.e., they can contain one ring (such as, for example, phenyl) or two or more rings, which may also be fused (such as, for example, naphthyl) or covalently bonded (such as, for example, biphenyl), or contain a combination of fused and linked rings. Heteroaryl groups contain one or more hetero-atoms, preferably selected from O, N, S, and Se.

[0451] Particular preference is given to mono-, bi- or tricyclic aryl groups having 6 to 25 C atoms and mono-, bi- or tricyclic heteroaryl groups having 5 to 25 ring atoms, which optionally contain fused rings and are optionally substituted. Preference is furthermore given to 5-, 6-, or 7-membered aryl and heteroaryl groups, in which, in addition, one or more CH groups may be replaced by N, S, or O in such a way that O atoms and/or S atoms are not linked directly to one another.

[0452] Preferred aryl groups are, for example, phenyl, biphenyl, terphenyl, [1,1:3,1 ]terphenyl-2-yl, naphthyl, anthracene, binaphthyl, phenanthrene, 9,10-dihydro-phenanthrene, pyrene, dihydropyrene, chrysene, perylene, tetracene, pentacene, benzopyrene, fluorene, indene, indenofluorene, spirobifluorene, etc.

[0453] Preferred heteroaryl groups are, for example, 5-membered rings, such as pyrrole, pyrazole, imidazole, 1,2,3-triazole, 1,2,4-triazole, tetrazole, furan, thiophene, selenophene, oxazole, isoxazole, 1,2-thiazole, 1,3-thiazole, 1,2,3-oxadiazole, 1,2,4-oxadiazole, 1,2,5-oxadiazole, 1,3,4-oxadiazole, 1,2,3-thiadiazole, 1,2,4-thiadiazole, 1,2,5-thiadiazole, 1,3,4-thiadiazole, 6-membered rings, such as pyridine, pyridazine, pyrimidine, pyrazine, 1,3,5-triazine, 1,2,4-triazine, 1,2,3-triazine, 1,2,4,5-tetrazine, 1,2,3,4-tetrazine, 1,2,3,5-tetrazine, or condensed groups, such as indole, isoindole, indolizine, indazole, benzimidazole, benzotriazole, purine, naphthimidazole, phenanthrimidazole, pyridimidazole, pyrazinimidazole, quinoxalinimidazole, benzoxazole, naphthoxazole, anthroxazole, phenanthroxazole, isoxazole, benzothiazole, benzofuran, isobenzofuran, dibenzofuran, quinoline, isoquinoline, pteridine, benzo-5,6-quinoline, benzo-6,7-quinoline, benzo-7,8-quinoline, benzoisoquinoline, acridine, phenothiazine, phenoxazine, benzopyridazine, benzopyrimidine, quinoxaline, phenazine, naphthyridine, azacarbazole, benzocarboline, phenanthridine, phenanthroline, thieno[2,3b]thiophene, thieno[3,2b]thiophene, dithienothiophene, isobenzothiophene, dibenzothiophene, benzothiophene, benzothiadiazothiophene, or combinations of these groups.

[0454] The aryl and heteroaryl groups mentioned above and below may also be substituted by alkyl, alkoxy, thioalkyl, fluorine, fluoroalkyl, or further aryl or heteroaryl groups.

[0455] The (non-aromatic) alicyclic and heterocyclic groups encompass both saturated rings, i.e., those containing exclusively single bonds, and partially unsaturated rings, i.e., those which may also contain multiple bonds. Heterocyclic rings contain one or more heteroatoms, preferably selected from Si, O, N, S, and Se.

[0456] The (non-aromatic) alicyclic and heterocyclic groups can be monocyclic, i.e., contain only one ring (such as, for example, cyclohexane), or polycyclic, i.e., contain a plurality of rings (such as, for example, decahydronaphthalene or bicyclooctane). Particular preference is given to saturated groups. Preference is furthermore given to mono-, bi-, or tricyclic groups having 5 to 25 ring atoms, which optionally contain fused rings and are optionally substituted. Preference is furthermore given to 5-, 6-, 7-, or 8-membered carbocyclic groups, in which, in addition, one or more C atoms may be replaced by Si, one or more CH groups may be replaced by N, and/or one or more non-adjacent CH.sub.2 groups may be replaced by O and/or S.

[0457] Preferred alicyclic and heterocyclic groups are, for example, 5-membered groups, such as cyclopentane, tetrahydrofuran, tetrahydrothiophene, or pyrrolidine; 6-membered groups, such as cyclohexane, silinane, cyclohexene, tetrahydropyran, tetrahydrothiopyran, 1,3-dioxane, 1,3-dithiane, or piperidine; 7-membered groups, such as cycloheptane; and fused groups, such as tetrahydronaphthalene, decahydronaphthalene, indane, bicyclo[1.1.1]pentane-1,3-diyl, bicyclo[2.2.2]octane-1,4-diyl, spiro[3.3]heptane-2,6-diyl, or octahydro-4,7-methanoindane-2,5-diyl.

[0458] Preferred substituents are, for example, solubility-promoting groups, such as alkyl or alkoxy; electron-withdrawing groups, such as fluorine, nitro, or nitrile; or substituents for increasing the glass transition temperature (Tg) in the polymer, in particular bulky groups, such as, for example, t-butyl, or optionally substituted aryl groups.

[0459] Preferred substituents, hereinafter also referred to as L.sup.S, are, for example, F, Cl, Br, I, CN, NO.sub.2, NCO, NCS, OCN, SCN, C(O)N(R.sup.x).sub.2, C(O)Y.sup.1, C(O)R.sup.x, N(R.sup.x).sub.2, straight-chain alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy, or alkoxycarbonyloxy each having 1 to 25 C atoms, or branched alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy, or alkoxycarbonyloxy each having 3 to 25 C atoms, in which one or more H atoms may optionally be replaced by F or C, optionally substituted silyl having 1 to 20 Si atoms, or optionally substituted aryl having 6 to 25, preferably 6 to 15, C atoms, wherein R.sup.X denotes H, F, C, CN, straight-chain alkyl having 1 to 25 C atoms, or branched or cyclic alkyl having 3 to 25 C atoms, wherein one or more non-adjacent CH.sub.2-groups are optionally replaced by O, S, CO, COO, OCO, or OCOO in such a manner that O- and/or S-atoms are not directly connected with each other, and wherein one or more H atoms are each optionally replaced by F, Cl, P, or P-Sp-, and Y.sup.1 denotes halogen.

[0460] Substituted silyl or aryl preferably means substituted by halogen, CN, R.sup.0, OR.sup.0, COR.sup.0, COOR.sup.0, OCOR.sup.0, or OCOOR.sup.0, wherein R.sup.0 denotes H or alkyl with 1 to 20 C atoms.

[0461] Particularly preferred substituents L are, for example, F, Cl, CN, NO.sub.2, CH.sub.3, C.sub.2H.sub.5, OCH.sub.3, OC.sub.2H.sub.5, COCH.sub.3, COC.sub.2H.sub.5, COOCH.sub.3, COOC.sub.2H.sub.5, CF.sub.3, OCF.sub.3, OCHF.sub.2, OC.sub.2F.sub.5, or furthermore phenyl.

[0462] A.sup.1 and A.sup.2 very preferably denote

##STR00174##

in which L has one of the meanings indicated above and r denotes 0, 1, 2, 3, or 4, in particular

##STR00175##

denotes

##STR00176##

[0463] The polymerizable group P is a group which is suitable for a polymerization reaction, such as, for example, free-radical or ionic chain polymerization, polyaddition, or polycondensation, or for a polymer-analogous reaction, for example addition or condensation onto a main polymer chain. Particular preference is given to groups for chain polymerization, in particular those containing a CC double bond or CC triple bond, and groups which are suitable for polymerization with ring opening, such as, for example, oxetane or epoxide groups.

[0464] Preferred groups P are selected from the group consisting of [0465] CH.sub.2CW.sup.1COO, CH.sub.2CW.sup.1CO,

##STR00177## CH.sub.2CW.sup.2(O).sub.k3, CW.sup.1CHCO(O).sub.k3, CW.sup.1CHCONH, CH.sub.2CW.sup.1CONH, CH.sub.3CHCHO, (CH.sub.2CH).sub.2CHOCO, (CH.sub.2CHCH.sub.2).sub.2CHOCO, (CH.sub.2CH).sub.2CHO, (CH.sub.2CHCH.sub.2).sub.2N, (CH.sub.2CHCH.sub.2).sub.2NCO, HOCW.sup.2W.sup.3, HSCW.sup.2W.sup.3, HW.sup.2N, HOCW.sup.2W.sup.3NH, CH.sub.2CW.sup.1CONH, CH.sub.2CH(COO).sub.k1-Phe-(O).sub.k2, CH.sub.2CH(CO).sub.k1-Phe-(O).sub.k2, Phe-CHCH, HOOC, OCN and W.sup.4W.sup.5W.sup.6Si, in which W.sup.1 denotes H, F, Cl, CN, CF.sub.3, phenyl, or alkyl having 1 to 5 C atoms, in particular H, F, Cl, or CH.sub.3, W.sup.2 and W.sup.3 each, independently of one another, denote H or alkyl having 1 to 5 C atoms, in particular H, methyl, ethyl, or n-propyl, W.sup.4, W.sup.5, and W.sup.6 each, independently of one another, denote Cl, oxaalkyl, or oxacarbonylalkyl having 1 to 5 C atoms, W.sup.7 and W.sup.a each, independently of one another, denote H, Cl, or alkyl having 1 to 5 C atoms, Phe denotes 1,4-phenylene, which is optionally substituted by one or more radicals L as defined above which are other than P-Sp-, k.sub.1, k.sub.2, and k.sub.3 each, independently of one another, denote 0 or 1, k.sub.3 preferably denotes 1, and k.sub.4 denotes an integer from 1 to 10.

[0466] Very preferred groups P are selected from the group consisting of [0467] CH.sub.2CW.sup.1COO, CH.sub.2CW.sup.1CO,

##STR00178##

CH.sub.2CW.sup.2O, CH.sub.2CW.sup.2, CW.sup.1CHCO(O).sub.k3, CW.sup.1CHCONH, CH.sub.2CW.sup.1CONH, (CH.sub.2CH).sub.2CHOCO, (CH.sub.2CHCH.sub.2).sub.2CHOCO, (CH.sub.2CH).sub.2CHO, (CH.sub.2CHCH.sub.2).sub.2N, (CH.sub.2CHCH.sub.2).sub.2NCO, CH.sub.2CW.sup.1CONH, CH.sub.2CH(COO).sub.k1, -Phe-(O).sub.k2, CH.sub.2CH(CO).sub.k1-Phe-(O).sub.k2, Phe-CHCH and W.sup.4W.sup.5W.sup.6Si, in which W.sup.1 denotes H, F, C, CN, CF.sub.3, phenyl, or alkyl having 1 to 5 C atoms, in particular H, F, C, or CH.sub.3, W.sup.2 and W.sup.3 each, independently of one another, denote H or alkyl having 1 to 5 C atoms, in particular H, methyl, ethyl, or n-propyl, W.sup.4, W.sup.5, and W.sup.6 each, independently of one another, denote Cl, oxaalkyl, or oxacarbonylalkyl having 1 to 5 C atoms, W.sup.7 and W.sup.8 each, independently of one another, denote H, Cl, or alkyl having 1 to 5 C atoms, Phe denotes 1,4-phenylene, k.sub.1, k.sub.2, and k.sub.3 each, independently of one another, denote 0 or 1, k.sub.3 preferably denotes 1, and k.sub.4 denotes an integer from 1 to 10.

[0468] Very particularly preferred groups P are selected from the group consisting of CH.sub.2CW.sup.1COO, in particular CH.sub.2CHCOO, CH.sub.2C(CH.sub.3)COO, and CH.sub.2CFCOO, furthermore CH.sub.2CHO, (CH.sub.2CH).sub.2CHOCO, (CH.sub.2CH).sub.2CHO,

##STR00179##

[0469] Further preferred polymerizable groups P are selected from the group consisting of vinyloxy, acrylate, methacrylate, fluoroacrylate, chloroacrylate, oxetane, and epoxide, most preferably from acrylate and methacrylate.

[0470] If the spacer group Sp is different from a single bond, it is preferably of the formula Sp-X, so that the respective radical P-Sp- conforms to the formula R-Sp-X, wherein: [0471] Sp denotes linear or branched alkylene having 1 to 20, preferably 1 to 12, C atoms, which is optionally mono- or polysubstituted by F, Cl, Br, I, or CN, and in which, in addition, one or more non-adjacent CH.sub.2 groups may each be replaced, independently of one another, by O, S, NH, N(R.sup.0), Si(R.sup.0R.sup.00), CO, COO, OCO, OCOO, SCO, COS, N(R.sup.00)COO, OCON(R.sup.0), N(R.sup.0)CON(R.sup.00), CHCH, or CC in such a way that O and/or S atoms are not linked directly to one another; [0472] X denotes O, S, CO, COO, OCO, OCOO, CON(R.sup.0), N(R.sup.0)CO, N(R.sup.0)CON(R.sup.00), OCH.sub.2, CH.sub.2O, SCH.sub.2, CH.sub.2S, CF.sub.2O, OCF.sub.2, CF.sub.2S, SCF.sub.2, CF.sub.2CH.sub.2, CH.sub.2CF.sub.2, CF.sub.2CF.sub.2, CHN, NCH, NN, CHCR.sup.0, CY.sup.2CY.sup.3, CC, CHCHCOO, OCOCHCH, or a single bond; [0473] R.sup.0 and R.sup.00 each, independently of one another, denote H or alkyl having 1 to 20 C atoms; and [0474] Y.sup.2 and Y.sup.3 each, independently of one another, denote H, F, C, or CN.

[0475] X is preferably O, S, CO, COO, OCO, OCOO, CONR, NRCO, NRCONR.sup.00, or a single bond.

[0476] Typical spacer groups Sp and -Sp-X are, for example, (CH.sub.2).sub.p1, (CH.sub.2).sub.p1O, (CH.sub.2).sub.p1OCO, (CH.sub.2).sub.p1COO, (CH.sub.2).sub.p1OCOO, (CH.sub.2CH.sub.2O).sub.q1CH.sub.2CH.sub.2, CH.sub.2CH.sub.2SCH.sub.2CH.sub.2, CH.sub.2CH.sub.2NHCH.sub.2CH.sub.2, or (SiR.sup.0R.sup.00O).sub.p1, in which p1 is an integer from 1 to 12, q1 is an integer from 1 to 3, and R.sup.0 and R.sup.00 have the meanings indicated above.

[0477] Particularly preferred groups Sp and -Sp-X are (CH.sub.2).sub.p1, (CH.sub.2).sub.p1O, (CH.sub.2).sub.p1OCO, (CH.sub.2).sub.p1COO, and (CH.sub.2).sub.p1OCOO, in which p1 and q1 have the meanings indicated above.

[0478] Particularly preferred groups Sp are, in each case straight-chain, ethylene, propylene, butylene, pentylene, hexylene, heptylene, octylene, nonylene, decylene, undecylene, dodecylene, octadecylene, ethyleneoxyethylene, methyleneoxybutylene, ethylenethioethylene, ethylene-N-methyliminoethylene, 1-methylalkylene, ethenylene, propenylene, and butenylene.

[0479] In a preferred embodiment of the invention, the compounds of formula P and its sub-formulae contain a spacer group Sp that is substituted by one or more polymerizable groups P, so that the group Sp-P corresponds to Sp(P).sub.s, with s being 2 (branched polymerizable groups).

[0480] Preferred compounds of formula P according to this preferred embodiment are those wherein s is 2, i.e., compounds which contain a group Sp(P).sub.2. Very preferred compounds of formula P according to this preferred embodiment contain a group selected from the following formulae:

X-alkyl-CHPPS1

X-alkyl-CH((CH.sub.2).sub.aaP)((CH.sub.2).sub.bbP)S2

XN((CH.sub.2).sub.aaP)((CH.sub.2).sub.bbP)S3

X-alkyl-CHPCH.sub.2CH.sub.2PS4

X-alkyl-C(CH.sub.2P)(CH.sub.2P)C.sub.aaH.sub.2aa+1S5

X-alkyl-CHPCH.sub.2PS6

X-alkyl-CPPC.sub.aaH.sub.2aa+1S7

X-alkyl-CHPCHPC.sub.aaH.sub.2aa+1S8 [0481] in which [0482] P is as defined in formula P, [0483] alkyl denotes a single bond, straight-chain alkylene having 1 to 12 C atoms, or branched alkylene having 3 to 12 C atoms, which is unsubstituted, monosubstituted, or polysubstituted by F, Cl or CN and in which one or more non-adjacent CH.sub.2 groups may each, independently of one another, be replaced by C(R.sup.0)C(R.sup.0), CC, N(R.sup.0), O, S, CO, COO, OCO, or OCOO in such a way that O and/or S atoms are not linked directly to one another, where R.sup.0 has the meaning indicated above, [0484] aa and bb each, independently of one another, denote 0, 1, 2, 3, 4, 5, or 6, and [0485] X has one of the meanings indicated for X, and is preferably O, CO, SO.sub.2, OCO, COO, or a single bond.

[0486] Preferred spacer groups Sp(P).sub.2 are selected from formulae S1, S2, and S3.

[0487] Very preferred spacer groups Sp(P).sub.2 are selected from the following sub-formulae:

CHPPS1a

OCHPPS1b

CH.sub.2CHPPS1c

OCH.sub.2CHPPS1d

CH(CH.sub.2P)(CH.sub.2P)S2a

OCH(CH.sub.2P)(CH.sub.2P)S2b

CH.sub.2CH(CH.sub.2P)(CH.sub.2P)S2c

OCH.sub.2CH(CH.sub.2P)(CH.sub.2P)S2d

CONH((CH.sub.2).sub.2P)((CH.sub.2).sub.2P)S3a.

[0488] In the compounds of formula P and its sub-formulae as described above and below, P is preferably selected from the group consisting of vinyloxy, acrylate, methacrylate, fluoroacrylate, chloroacrylate, oxetane, and epoxide, most preferably from acrylate and methacrylate.

[0489] Further preferred are compounds of formula P and its sub-formulae as described above and below, wherein all polymerizable groups P that are present in the compound have the same meaning, and very preferably denote acrylate or methacrylate, most preferably methacrylate.

[0490] In the compounds of formula P and its sub-formulae as described above and below, R preferably denotes P-Sp-.

[0491] Further preferred are compounds of formula P and its sub-formulae as described above and below, wherein Sp denotes a single bond or (CH.sub.2).sub.p1, O(CH.sub.2).sub.p1, OCO(CH.sub.2).sub.p1, or COO(CH.sub.2).sub.p1, wherein p1 is 2, 3, 4, 5, or 6, and, if Sp is O(CH.sub.2).sub.p1, OCO(CH.sub.2).sub.p1, or COO(CH.sub.2).sub.p1, the O-atom or CO-group, respectively, is linked to the benzene ring.

[0492] Further preferred are compounds of formula P and its sub-formulae as described above and below, wherein at least one group Sp is a single bond.

[0493] Further preferred are compounds of formula P and its sub-formulae as described above and below, wherein at least one group Sp is different from a single bond, and is preferably selected from (CH.sub.2).sub.p1, O(CH.sub.2).sub.p1, OCO(CH.sub.2).sub.p1, or COO(CH.sub.2).sub.p1, wherein p1 is 2, 3, 4, 5, or 6, and, if Sp is O(CH.sub.2).sub.p1, OCO(CH.sub.2).sub.p1, or COO(CH.sub.2).sub.p1, the O-atom or CO-group, respectively, is linked to the benzene ring.

[0494] Very preferred groups -A.sup.1-(Z-A.sup.2).sub.z- in formula P are selected from the following formulae:

##STR00180## [0495] wherein at least one benzene ring is substituted by at last one group L and the benzene rings are optionally further substituted by one or more groups L or P-Sp-.

[0496] Preferred compounds of formula P and their sub-formulae are selected from the following preferred embodiments, including any combination thereof: [0497] All groups P in the compound have the same meaning as described elsewhere in this disclosure; [0498] A.sup.1-(Z-A.sup.2).sub.z- is selected from formulae A1, A2, and A5; [0499] the compounds contain exactly two polymerizable groups (represented by the groups P); [0500] the compounds contain exactly three polymerizable groups (represented by the groups P); [0501] P is selected from the group consisting of acrylate, methacrylate, and oxetane, very preferably acrylate or methacrylate; [0502] P is methacrylate; [0503] all groups Sp are a single bond; [0504] at least one of the groups Sp is a single bond and at least one of the groups Sp is different from a single bond; [0505] Sp, when being different from a single bond, is (CH.sub.2).sub.p2, (CH.sub.2).sub.p2O, (CH.sub.2).sub.p2COO, (CH.sub.2).sub.p2OCO, wherein p2 is 2, 3, 4, 5, or 6, and the O-atom or the CO-group, respectively, is connected to the benzene ring; [0506] Sp is a single bond or denotes (CH.sub.2).sub.p2, (CH.sub.2).sub.p2O, (CH.sub.2).sub.p2COO, or (CH.sub.2).sub.p2OCO, wherein p2 is 2, 3, 4, 5, or 6, and the O-atom or the CO-group, respectively, is connected to the benzene ring; [0507] R denotes P-Sp-; [0508] R does not denote or contain a polymerizable group; [0509] R does not denote or contain a polymerizable group and denotes straight-chain alkyl having 1 to 25 C atoms or branched or cyclic alkyl having 3 to 25 C atoms, wherein one or more non-adjacent CH.sub.2-groups are optionally replaced by O, S, CO, COO, OCO, or OCOO in such a manner that O- and/or S-atoms are not directly connected with each other, and wherein one or more H atoms are each optionally replaced by F, Cl or L.sup.a; [0510] L or L denote F, Cl, or CN; and [0511] L is F.

[0512] Suitable and preferred compounds of formula P are selected from the following formulae:

##STR00181## ##STR00182## ##STR00183## ##STR00184## ##STR00185## [0513] in which the individual radicals have the following meanings: [0514] P.sup.1, P.sup.2 and P.sup.3 each, independently of one another, denote an acrylate or methacrylate group; [0515] Sp.sup.1, Sp.sup.2, and Sp.sup.3 each, independently of one another, denote a single bond or a spacer group having one of the meanings indicated above and below for Sp, and particularly preferably denote (CH.sub.2).sub.p1, (CH.sub.2).sub.p1O, (CH.sub.2).sub.p1COO, (CH.sub.2).sub.p1OCO, or (CH.sub.2).sub.p1OCOO, in which p1 is an integer from 1 to 12, where, in addition, one or more of the radicals P.sup.1-Sp.sup.1-, P.sup.2-Sp.sup.2-, and P.sup.3-Sp.sup.3- may denote R.sup.aa, with the proviso that at least one of the radicals P.sup.1-Sp.sup.1-, P.sup.2-Sp.sup.2-, and P.sup.3-Sp.sup.3- present is different from R.sup.aa; [0516] R.sup.aa denotes H, F, Cl, CN, straight-chain alkyl having 1 to 25 C atoms, or branched alkyl having 3 to 25 C atoms, in which, in addition, one or more non-adjacent CH.sub.2 groups may each be replaced, independently of one another, by C(R.sup.0)C(R.sup.00), CC, N(R.sup.0), O, S, CO, COO, OCO, or OCOO in such a way that O and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by F, Cl, CN, or P.sup.1-Sp.sup.1-, particularly preferably straight-chain, optionally mono- or polyfluorinated alkyl, alkoxy, alkenyl, alkynyl, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyl-oxy, or alkoxycarbonyloxy having 1 to 12 C atoms, 2 to 12 C atoms, or 3 to 12 C atoms, or branched optionally mono- or polyfluorinated alkyl, alkoxy, alkenyl, alkynyl, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 3 to 12 C atoms (where the alkenyl and alkynyl radicals have at least two C atoms and the branched radicals have at least three C atoms); [0517] R.sup.0, R.sup.00 each, independently of one another and identically or differently on each occurrence, denote H or alkyl having 1 to 12 C atoms; [0518] R.sup.y and R.sup.z each, independently of one another, denote H, F, CH.sub.3, or CF.sub.3; [0519] X.sup.1, X.sup.2, and X.sup.3 each, independently of one another, denote COO, OCO, or a single bond; [0520] Z.sup.1 denotes O, CO, C(R.sup.yR.sup.z), or CF.sub.2CF.sub.2; [0521] Z.sup.2 and Z.sup.3 each, independently of one another, denote COO, OCO, CH.sub.2O, OCH.sub.2, CF.sub.2O, OCF.sub.2, or (CH.sub.2).sub.n, where n is 2, 3, or 4; [0522] L on each occurrence, identically or differently, denotes F, Cl, CN, or straight-chain, optionally mono- or polyfluorinated alkyl, alkoxy, alkenyl, alkynyl, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy, or alkoxycarbonyloxy having 1 to 12 C atoms, or branched, optionally mono- or polyfluorinated alkyl, alkoxy, alkenyl, alkynyl, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy, or alkoxycarbonyloxy having 3 to 12 C atoms, preferably F; [0523] L and L each, independently of one another, denote H, F, or Cl; [0524] k denotes 0 or 1; [0525] r denotes 0, 1, 2, 3, or 4; [0526] s denotes 0, 1, 2, or 3; [0527] t denotes 0, 1, or 2; and [0528] x denotes 0 or 1.

[0529] Especially preferred are compounds of the formulae P2, P13, P17, P22, P23, P24, P30, P31, and P32.

[0530] Further preferred are tri-reactive compounds P15 to P30, in particular P17, P18, P19, P22, P23, P24, P25, P26, P30, P31, and P32.

[0531] In the compounds of formulae P1 to P32 the group

##STR00186##

is preferably

##STR00187## [0532] wherein L on each occurrence, identically or differently, has one of the meanings given above or below, and is preferably F, Cl, CN, NO.sub.2, CH.sub.3, C.sub.2H.sub.5, C(CH.sub.3).sub.3, CH(CH.sub.3).sub.2, CH.sub.2CH(CH.sub.3)C.sub.2H.sub.5, OCH.sub.3, OC.sub.2H.sub.5, COCH.sub.3, COC.sub.2H.sub.5, COOCH.sub.3, COOC.sub.2H.sub.5, CF.sub.3, OCF.sub.3, OCHF.sub.2, OC.sub.2F.sub.5, or P-Sp-, very preferably F, Cl, CN, CH.sub.3, C.sub.2H.sub.5, OCH.sub.3, COCH.sub.3, OCF.sub.3, or P-Sp-, more preferably F, Cl, CH.sub.3, OCH.sub.3, COCH.sub.3, or OCF.sub.3, especially F or CH.sub.3.

[0533] Very particularly preferred compounds of the formula P are selected from Table E below.

[0534] For the production of PSA displays, the polymerizable compounds contained in the LC medium are polymerized or crosslinked (if one compound contains two or more polymerizable groups) by in-situ polymerization in the LC medium between the substrates of the LC display, optionally while a voltage is applied to the electrodes.

[0535] The structure of the PSA displays according to the invention corresponds to the usual geometry for PSA displays, as described in the prior art cited at the outset. Geometries without protrusions are preferred, in particular those in which, in addition, the electrode on the color filter side is unstructured and only the electrode on the TFT side has slots. Particularly suitable and preferred electrode structures for PS-VA displays are described, for example, in US 2006/0066793 A1.

[0536] A preferred PSA type LC display of the present invention comprises: [0537] a first substrate including a pixel electrode defining pixel areas, the pixel electrode being connected to a switching element disposed in each pixel area and optionally including a micro-slit pattern, and optionally a first alignment layer disposed on the pixel electrode; [0538] a second substrate including a common electrode layer, which may be disposed on the entire portion of the second substrate facing the first substrate, and optionally a second alignment layer; and [0539] an LC layer disposed between the first and second substrates and including an LC medium comprising a polymerizable component comprising one or more compounds of formula R and a liquid crystal host including elements as described above and below, wherein the polymerizable component may also be polymerized.

[0540] The first and/or second alignment layer controls the alignment direction of the LC molecules of the LC layer. For example, in PS-VA displays, the alignment layer is selected such that it imparts to the LC molecules homeotropic (or vertical) alignment (i.e., perpendicular to the surface) or tilted alignment. Such an alignment layer may for example comprise a polyimide, which may also be rubbed, or may be prepared by a photoalignment method.

[0541] The LC layer with the LC medium can be deposited between the substrates of the display by methods that are conventionally used by display manufacturers, for example the so-called one drop filling (ODF) method. The polymerizable component of the LC medium is then polymerized for example by UV photopolymerization. The polymerization can be carried out in one step or in two or more steps.

[0542] The PSA display may comprise further elements, like a color filter, a black matrix, a passivation layer, optical retardation layers, transistor elements for addressing the individual pixels, etc., all of which are well known to the person skilled in the art and can be employed without inventive skill.

[0543] The electrode structure can be designed by the skilled person depending on the individual display type. For example, for PS-VA displays a multi-domain orientation of the LC molecules can be induced by providing electrodes having slits and/or bumps or protrusions in order to create two, four, or more different tilt alignment directions.

[0544] Upon polymerization the polymerizable compounds form a crosslinked polymer, which causes a certain pretilt of the LC molecules in the LC medium. Without wishing to be bound to a specific theory, it is believed that at least a part of the crosslinked polymer, which is formed by the polymerizable compounds, will phase-separate or precipitate from the LC medium and form a polymer layer on the substrates, electrodes, or the alignment layer provided thereon. Microscopic measurement data (like SEM and AFM) have confirmed that at least a part of the formed polymer accumulates at the LC/substrate interface.

[0545] The polymerization can be carried out in one step. It is also possible firstly to carry out the polymerization, optionally while applying a voltage, in a first step in order to produce a pretilt angle, and subsequently, in a second polymerization step without an applied voltage, to polymerize or crosslink the compounds which have not reacted in the first step (end curing).

[0546] Suitable and preferred polymerization methods are, for example, thermal or photopolymerization, preferably photopolymerization, in particular UV-induced photopolymerization, which can be achieved by exposure of the polymerizable compounds to UV radiation.

[0547] Optionally one or more polymerization initiators are added to the LC medium. Suitable conditions for the polymerization and suitable types and amounts of initiators are known to the person skilled in the art and are described in the literature. Suitable for free-radical polymerization are, for example, the commercially available photoinitiators Irgacure651, Irgacure184, Irgacure907, Irgacure369 or Darocure1173 (Ciba AG). If a polymerization initiator is employed, its proportion is preferably 0.001 to 5% by weight, particularly preferably 0.001 to 1% by weight.

[0548] The polymerizable compounds according to the invention are also suitable for polymerization without an initiator, which is accompanied by considerable advantages, such as, for example, lower material costs and in particular less contamination of the LC medium by possible residual amounts of the initiator or degradation products thereof. The polymerization can thus also be carried out without the addition of an initiator. In a preferred embodiment, the LC medium thus does not contain a polymerization initiator.

[0549] The LC medium may also comprise one or more stabilizers in order to prevent undesired spontaneous polymerization of the RMs, for example during storage or transport. Suitable types and amounts of stabilizers are known to the person skilled in the art and are described in the literature. Particularly suitable are, for example, the commercially available stabilizers from the Irganox series (Ciba AG), such as, for example, Irganox 1076. If stabilizers are employed, their proportion, based on the total amount of RMs or the polymerizable component (component P), is preferably 10-500,000 ppm, particularly preferably 50-50,000 ppm.

[0550] The polymerizable compounds of formula P in particular show good UV absorption in, and are therefore especially suitable for, a process of preparing a PSA display including one or more of the following features: [0551] the polymerizable medium is exposed to UV light in the display in a 2-step process, including a first UV exposure step (UV-1 step) to generate the tilt angle, and a second UV exposure step (UV-2 step) to finish polymerization; [0552] the polymerizable medium is exposed to UV light in the display generated by an energy-saving UV lamp (also known as green UV lamps). These lamps are characterized by a relative low intensity (1/100-1/10 of a conventional UV1 lamp) in their absorption spectra from 300-380 nm, and are preferably used in the UV2 step, but are optionally also used in the UV1 step when avoiding high intensity is necessary for the process; [0553] the polymerizable medium is exposed to UV light in the display generated by a UV lamp with a radiation spectrum that is shifted to longer wavelengths, preferably 340 nm or more, to avoid short UV light exposure in the PS-VA process.

[0554] Both using lower intensity and a UV shift to longer wavelengths protect the organic layer against damage that may be caused by the UV light.

[0555] A preferred embodiment of the present invention relates to a process for preparing a PSA display as described above and below, comprising one or more of the following features: [0556] the polymerizable LC medium is exposed to UV light in a 2-step process, including a first UV exposure step (UV-1 step) to generate the tilt angle, and a second UV exposure step (UV-2 step) to finish polymerization; [0557] the polymerizable LC medium is exposed to UV light generated by a UV lamp having an intensity of from 0.5 mW/cm.sup.2 to 10 mW/cm.sup.2 in the wavelength range from 300-380 nm, preferably used in the UV2 step, and optionally also in the UV1 step; and [0558] the polymerizable LC medium is exposed to UV light having a wavelength of 340 nm or more, and preferably 400 nm or less.

[0559] This preferred process can be carried out for example by using the desired UV lamps or by using a band pass filter and/or a cut-off filter, which are substantially transmissive for UV light with the respective desired wavelength(s) and are substantially blocking light with the respective undesired wavelengths. For example, when irradiation with UV light of wavelengths of 300-400 nm is desired, UV exposure can be carried out using a wide band pass filter being substantially transmissive for wavelengths 300 nm<<400 nm. When irradiation with UV light of wavelength of more than 340 nm is desired, UV exposure can be carried out using a cut-off filter being substantially transmissive for wavelengths >340 nm.

[0560] Substantially transmissive means that the filter transmits a substantial part, preferably at least 50% of the intensity, of incident light of the desired wavelength(s). Substantially blocking means that the filter does not transmit a substantial part, preferably at least 50% of the intensity, of incident light of the undesired wavelengths. Desired (undesired) wavelength e.g., in case of a band pass filter, means the wavelengths inside (outside) the given range of , and in case of a cut-off filter, means the wavelengths above (below) the given value of .

[0561] This preferred process enables the manufacture of displays by using longer UV wavelengths, thereby reducing or even avoiding the hazardous and damaging effects of short UV light components.

[0562] UV radiation energy is in general from 6 to 100 J, depending on the production process conditions.

[0563] Preferably the LC medium according to the present invention essentially consist of a polymerizable component (component P) comprising or one or more polymerizable compounds of formula P, and an LC host mixture, and an optically active component comprising one or more chiral dopants, as described above and below. However, the LC medium may additionally comprise one or more further components or additives, preferably selected from the list including but not limited to co-monomers, polymerization initiators, inhibitors, stabilizers, surfactants, wetting agents, lubricating agents, dispersing agents, hydrophobing agents, adhesive agents, flow improvers, defoaming agents, deaerators, diluents, reactive diluents, auxiliaries, colorants, dyes including dichroic dyes, pigments, and nanoparticles.

[0564] Particular preference is given to LC media comprising one, two, or three polymerizable compounds of formula P.

[0565] Preferably the proportion of compounds of formula P in the LC medium is from >0 to <5%, very preferably from >0 to <1%, most preferably from 0.01 to 0.5%.

[0566] In a preferred embodiment, the medium according to the invention preferably comprises one or more compounds of formula S in a total concentration in the range of from 10 ppm to 2000 ppm, more preferably from 100 ppm to 1000 ppm, still more preferably from 150 ppm to 500 ppm, very preferably from 200 ppm to 400 ppm, and in particular from 250 to 300 ppm.

[0567] The medium according to the invention preferably has negative dielectric anisotropy.

[0568] The liquid crystal mixture according to the invention is nematic, preferably at a temperature of 20 C. or less, preferably at 30 C. or less, very preferably at 40 C. or less.

[0569] It is advantageous for the liquid-crystalline medium according to the invention to preferably have a nematic phase from 20 C. to 70 C., particularly preferably from 30 C. to 80 C., very particularly preferably from 40 C. to 80 C.

[0570] The expression have a nematic phase herein means on the one hand that no smectic phase and no crystallization are observed at low temperatures at the corresponding temperature and on the other hand that clearing (phase transition to the isotropic phase) still does not occur on heating from the nematic phase. The investigation at low temperatures is carried out in a flow viscometer at the corresponding temperature and checked by storage in test cells having a layer thickness corresponding to the electro-optical use for at least 100 hours. If the storage stability at a temperature of 20 C. in a corresponding test cell is 1000 h or more, the medium is referred to as stable at this temperature. At temperatures of 30 C. and 40 C., the corresponding times are 500 h and 250 h respectively. At high temperatures, the clearing point is measured by conventional methods in capillaries.

[0571] In a preferred embodiment, the medium according to the invention has a clearing temperature of 75 C. or more, preferably of 80 C. or more, more preferably of 82 C. or more and in particular of 83 C. or more.

[0572] In a preferred embodiment, the liquid-crystal mixture according to the invention has a dielectric anisotropy of 2.0 to 6.0, more preferably of 2.2 to 5.0, very preferably 2.4 to 4.3, and in particular 3.0 to 4.0.

[0573] The rotational viscosity .sub.1 at 20 C. is preferably in the range of from 50 to 250 mPa.Math.s, more preferably from 70 to 140 mPa.Math.s.

[0574] The medium according to the invention preferably comprises: [0575] one or more compounds of the formula ST in a total concentration in the range of from 1 ppm to 2000 ppm, more preferably from 50 ppm to 1500 ppm, still more preferably from 150 ppm to 900 ppm, very preferably from 200 ppm to 700 ppm, and in particular from 250 ppm to 550 ppm; [0576] one or more compounds of the formula Ia in a total concentration on the range of from 1 ppm to 500 ppm, more preferably from 10 ppm to 400 ppm, still more preferably from 20 ppm to 300 ppm, very preferably from 50 ppm to 200 ppm, and in particular from 70 ppm to 130 ppm; and [0577] one or more compounds of the formula Ib in a total concentration on the range of from 1 ppm to 1000 ppm, more preferably from 10 ppm to 800 ppm, still more preferably from 50 ppm to 750 ppm, very preferably from 70 ppm to 500 ppm, and in particular from 80 ppm to 350 ppm.

[0578] Further preferred embodiments, taken alone or in combination with one another are the following.

[0579] The medium preferably comprises: [0580] one or more compounds of formula IIA, preferably IIA-10 and optionally IIA-2, more preferably one or more compounds CCY-n-Om, in particular CCY-4-02, CCY-3-02, CCY-3-03, CCY-3-01, and/or CCY-5-02, preferably in a total concentration in the range of from 2% to 35%, more preferably from 5% to 30%, particularly preferably from 7% to 28%; [0581] one or more compounds of formula IIA-10, more preferably one or more compounds CCY-n-Om, in particular CCY-4-02, CCY-3-02, CCY-3-03, CCY-3-01, and/or CCY-5-02, preferably in a total concentration in the range of from 2% to 25%, more preferably from 5% to 20%, particularly preferably from 7% to 18%; [0582] one or more compounds of the formula IIA-Y, preferably in a total concentration in the range of from 1% to 15%, more preferably from 2% to 12%, very preferably from 3% to 10%; [0583] one or more compounds of formula IID, preferably selected from the compounds of the formulae IID-4 and IID-10, more preferably IID-4, very preferably CLY-n-Om, in particular CLY-2-04, CLY-3-02, and/or CLY-3-03, preferably in a total concentration in the range of from 2% to 42%, more preferably from 15% to 37%, particularly preferably from 20% to 35%;
and/or [0584] one or more compounds of formula IID-10, preferably CLOY-n-Om, in particular CLOY-3-02, preferably in a total concentration in the range of from 2% to 35%, more preferably, from 4% to 30%, particularly preferably from 6% to 26%;
and/or [0585] one or more compounds of the formula III, preferably of the formula III-2 and/or III-3, more preferably of the formula III-2-6 and/or III-3, in particular one or more compounds B(S)-nOOm and/or COB(S)-n-Om, very particularly B(S)-2O-O4, B(S)-2O-O5, B(S)-2O-O6, B(S)-2O-O1 (c5), B(S)-4O-O1 (c5), and/or COB(S)-2-O4, preferably in a total concentration in the range of from 1% to 15%, more preferably from 2% to 12% and very preferably from 3% to 10%;
and/or [0586] one or more compounds of the formula III and/or PH-1, preferably of the formula III-2 and/or BP-3, more preferably of the formula III-2-6, in particular selected from B(S)-2O-O4, B(S)-2O-O5 and B(S)-2O-O6, preferably in a total concentration in the range of from 1% to 15%, more preferably from 2% to 12%, and very preferably from 3% to 10%;
and/or [0587] one or more compounds of formula IV, preferably in a total concentration in the range of from 25% to 70%, more preferably from 30% to 60%, particularly preferably from 40% to 55%;
and/or [0588] one or more compounds of the formula IV-1, preferably IV-1-6, preferably in a total concentration in the range of from 1% to 20%, more preferably from 1% to 10%, and very preferably from 1% to 8%;
and/or [0589] the compound(s) of the formula CC-3-V1 and/or CC-4-V1, in a total concentration in the range of from 2 to 20%, more preferably from 3% to 15%, particularly preferably from 5% to 10%,
and/or [0590] one or more compounds of the formula IV-3-1, preferably CC-3-V and/or CC-4-V, preferably in a total concentration in the range of from 20% to 60%, more preferably from 25% to 52% and very preferably from 28% to 48%;
and/or [0591] one or more compounds of the formula IVa, more preferably of the formula IVa-2, in particular CP-3-O2, in a total concentration in the range of from 0.5% to 8%, more preferably from 1% to 6%, very preferably from 2% to 5%;
and/or [0592] one or more compounds of the formula V, more preferably selected from the compounds of the formulae V-2-1 and V-2-2, in particular CCP-n-m and/or CCP-Vn-m and/or CPP-n-m, very particularly selected from the group consisting of CCP-3-1, CCP-V-1, CCP-V2-1 and CPP-3-2, preferably in a total concentration in the range of from 1% to 20%, more preferably from 2% to 17%, very preferably from 3% to 14%;
and/or [0593] one or more compounds selected from the compounds of the formulae V-1-1 and V-1-6, in particular CCC-n-m and/or CCC-n-V, very particularly CCC-3-V and/or CCC-V-V, preferably in a total concentration in the range of from 1% to 20%, more preferably from 2% to 17%, very preferably from 3% to 14%;
and/or [0594] one or more compounds of the formula CL, more preferably of the formula CL-3, very preferably selected form the compounds CLP-V-m, CLP-V-Om, CLP-n-m, and CLP-n-Om, in which n and m independently are 1, 2, 3, 4, or 5, preferably in a total concentration in the range of from 1% to 12%, more preferably from 2% to 10% and very preferably from 3% to 7%;
and/or [0595] less than 10% in total of one or more compounds of the formula V, more preferably less than 5%, very preferably less than 2%, in particular 0%;
and/or [0596] one or more compounds of the formula COYOIC-n-m;
and/or [0597] one or more compounds of the formula COY-n-Om and/or CCOY-n-Om;
and/or [0598] 0.1% to 3% of the compound PPGU-3-F and/or PPGU-(c5)-F;
and/or 0.1 to 3% of 2-(4-methylphenyl)-6-propylnaphthalene:

##STR00188##

[0599] The medium optionally comprises: [0600] one or more compounds of the formula IIB in a total concentration on the range of from 1% to 15%, more preferably from 3% to 12% and very preferably from 4% to 10%;
and/or [0601] one or more compounds of the formula IIC in a total concentration on the range of from 0.5% to 8%, more preferably from 1% to 5% and very preferably from 2% to 3%;
and/or [0602] one or more compounds of the formula CCU-n-F.

[0603] The liquid-crystal media according to the invention have high values for the voltage holding ratio in liquid-crystal cells.

[0604] In general, liquid-crystal media having a low addressing voltage or threshold voltage exhibit a lower voltage holding ratio than those having a higher addressing voltage or threshold voltage and vice versa.

[0605] As used herein, the term dielectrically positive compounds denotes compounds having a >1.5, the term dielectrically neutral compounds denotes those having 1.51.5, and the term dielectrically negative compounds denotes those having <1.5. The dielectric anisotropy of the compounds is determined here by dissolving 10% of the compounds in a liquid-crystalline host and determining the capacitance of the resultant mixture in at least one test cell in each case having a layer thickness of 20 m with homeotropic and with homogeneous surface alignment at 1 kHz. The measurement voltage is typically 0.5 V to 1.0 V but is always lower than the capacitive threshold of the respective liquid-crystal mixture investigated.

[0606] All temperature values indicated for the present invention are in C.

[0607] The mixtures according to the invention are suitable for all VA-TFT applications, such as, for example, VAN, MVA, (S)-PVA, ASV, PSA (polymer sustained VA), and PS-VA (polymer stabilized VA). They are furthermore suitable for IPS (in-plane switching) and FFS (fringe field switching) applications having negative , in particular UB-FFS.

[0608] It goes without saying for the person skilled in the art that the VA, IPS, or FFS mixture according to the invention may also comprise compounds in which, for example, H, N, O, Cl, and F have been replaced by the corresponding isotopes.

[0609] The compounds according to the present invention can be synthesized by or in analogy to known methods described in the literature (for example in the standard works such as Houben-Weyl, Methoden der Organischen Chemie [Methods of Organic Chemistry], Georg-Thieme-Verlag, Stuttgart), under reaction conditions which are known and suitable for said reactions. Use may also be made here of variants which are known per se but are not mentioned here. In particular, they can be prepared as described in or in analogy to the following reaction schemes. Further methods for preparing the inventive compounds can be taken from the examples.

[0610] Other mesogenic compounds which are not explicitly mentioned above can optionally and advantageously also be used in the media in accordance with the present invention. Such compounds are known to the person skilled in the art.

[0611] For the present invention and in the following examples, the structures of the liquid-crystal compounds are indicated by means of acronyms, with the transformation into chemical formulae taking place in accordance with Tables A to C below. All radicals C.sub.mH.sub.2m+1, C.sub.nH.sub.2n+1, C.sub.lH.sub.2l+1, C.sub.mH.sub.2m1, C.sub.nH.sub.2n1, and C.sub.lH.sub.2l1 are straight-chain alkyl radicals or alkylene radicals, in each case having n, m, and l C atoms, respectively. Preferably, n, m, and l are independently of each other 1, 2, 3, 4, 5, 6, or, 7. Table A shows the codes for the ring elements of the nuclei of the compound, Table B lists the bridging units, and Table C lists the meanings of the symbols for the left- and right-hand end groups of the molecules. The acronyms are composed of the codes for the ring elements with optional linking groups, followed by a first hyphen and the codes for the left-hand end group, and a second hyphen and the codes for the right-hand end group. Table D shows illustrative structures of compounds together with their respective abbreviations.

TABLE-US-00001 TABLE A Ring elements C [00189] D [00190] DI [00191] A [00192] AI [00193] P [00194] G [00195] GI [00196] U [00197] UI [00198] U(1) [00199] U(1)I [00200] Y [00201] P(F, Cl)Y [00202] P(Cl, F)Y [00203] np [00204] n3f [00205] nN3fl [00206] th [00207] thl [00208] tH2f [00209] tH2fl [00210] o2f [00211] o2fl [00212] dh [00213] O [00214] S [00215] cpS [00216] K [00217] KI [00218] L [00219] LI [00220] F [00221] FI [00222] B [00223] B(S) [00224] Bh [00225] Bh(S) [00226] Bf [00227] Bf(S) [00228] Bfi [00229] Bfi(S) [00230] B(P) [00231] B(A) [00232]

TABLE-US-00002 TABLE B Bridging units E CH.sub.2CH.sub.2 V CHCH T CC W CF.sub.2CF.sub.2 B CFCF Z COO ZI OCO X CFCH XI CHCF O CH.sub.2O OI OCH.sub.2 Q CF.sub.2O QI OCF.sub.2

TABLE-US-00003 TABLE C End groups On the left indicidually or in combi- On the right individually or in com- nation bination -n- C.sub.nH.sub.2n+1 -n C.sub.nH.sub.2n+1 -nO- C.sub.nH.sub.2n+1O -On OC.sub.nH.sub.2n+1 -V- CH.sub.2CH -V CHCH.sub.2 -nV- C.sub.nH.sub.2n+1CHCH -nV C.sub.nH.sub.2nCHCH.sub.2 -Vn- CH.sub.2CHC.sub.nH.sub.2n -Vn CHCHC.sub.nH.sub.2n+1 -nVm- C.sub.nH.sub.2n+1CHCHC.sub.mH.sub.2m -nVm C.sub.nH.sub.2nCHCHC.sub.mH.sub.2m+1 N NC N CN S SCN S NCS F F F F CL Cl CL Cl -M- CFH.sub.2 -M CFH.sub.2 -D- CF.sub.2H -D CF.sub.2H -T- CF.sub.3 -T CF.sub.3 -MO- CFH.sub.2O -OM OCFH.sub.2 -DO- CF.sub.2HO -OD OCF.sub.2H -TO- CF.sub.3O -OT OCF.sub.3 -A- HCC -A CCH -nA- C.sub.nH.sub.2n+1CC -An CCC.sub.nH.sub.2n+1 -NA- NCCC -AN CCCN -(cn)- [00233] -(cn) [00234] -(cn)m- [00235] -m(cn) [00236] -(c5-1en)m- [00237] -m(c5-1en) [00238] -(c5-2en)m- [00239] -m(c5-2en) [00240] -(c5-3en)m- [00241] -m(c5-3en) [00242] On the left only in combination On the right only in combination - . . . n . . . - C.sub.nH.sub.2n - . . . n . . . C.sub.nH.sub.n - . . . M . . . - CFH - . . . M . . . CFH - . . . D . . . - CF.sub.2 - . . . D . . . CF.sub.2 - . . . V . . . - CHCH - . . . V . . . CHCH - . . . Z . . . - COO - . . . Z . . . COO - . . . Zl . . . - OCO - . . . Zl . . . OCO - . . . K . . . - CO - . . . K . . . CO - . . . W . . . - CFCF - . . . W . . . CFCF in which n and m are each an integer, and the three dots . . . are placeholders for other abbreviations from this table.

[0612] The medium according to the invention preferably comprises one or more compounds of the compounds mentioned in Table D below.

[0613] The following abbreviations are used: [0614] n, m, k, and l are, independently of one another, each an integer, preferably 1 to 9, preferably 1 to 7; k and l possibly may be also 0 and preferably are 0 to 4, more preferably 0 or 2, and most preferably 2; n preferably is 1, 2, 3, 4, or 5; in the combination -nO, l preferably is 1, 2, 3 or 4, preferably 2 or 4; m preferably is 1, 2, 3, 4, or 5; in the combination Om, m preferably is 1, 2, 3 or 4, more preferably 2 or 4; the combination -IVm m preferably is 2V1.

TABLE-US-00004 TABLE D [00243] CC-n-m [00244] CC-n-Om [00245] CC-n-V [00246] CC-n-Vm [00247] CC-n-IV [00248] CC-n-IVm [00249] CC-V-V [00250] CC-V-IV [00251] CC-V-Vm [00252] CC-Vk-IV [00253] CC-nV-IV [00254] CC-nV-Vm [00255] CC-n-VV [00256] CC-n-VVm [00257] CVC-n-V [00258] CVC-n-Vm [00259] CP-n-m [00260] CP-n-Om [00261] PP-n-m [00262] PP-n-Om [00263] CCC-n-m [00264] CCC-n-V [00265] CCC-V-V [00266] CCP-n-m [00267] CCU-n-F [00268] CCP-n-Om [00269] CCP-V-m [00270] CCP-nV-m [00271] CCP-VI-m [00272] CCP-nVI-m [00273] CCOC-n-m [00274] CCZC-n-m [00275] CCVC-n-m [00276] CCVC-n-V [00277] CCVC-n-IV [00278] CLP-n-m [00279] CLP-V-n [00280] CPP-n-m [00281] CPG-n-m [00282] CGP-n-m [00283] PGP-n-m [00284] PGP-n-IV [00285] PGS-n-m [00286] PUS-n-m [00287] PYS-n-m [00288] SGP-m-n [00289] SPY-m-On [00290] cpSY-m-On [00291] cpSY-m-On(c3) [00292] cpSPY-m-On [00293] PGP-n-IVm [00294] CCZPC-n-m [00295] CLPC-n-m [00296] CPPC-n-m [00297] CGPC-n-m [00298] CPGP-n-m [00299] PPGU-n-F [00300] CY-V-n [00301] CY-V-On [00302] CY-nV-m [00303] CY-nV-Om [00304] CY-VI-m [00305] CY-VI-Om [00306] CY-nVI-m [00307] CY-nVI-Om [00308] PY-V-n [00309] PY-V-On [00310] PY-nV-m [00311] PY-nV-Om [00312] PY-VI-m [00313] PY-VI-Om [00314] PY-nVI-m [00315] PY-nVI-Om [00316] CCY-V-n [00317] CCY-V-On [00318] CCY-nV-m [00319] CCY-nV-Om [00320] CCY-VI-m [00321] CCY-VI-Om [00322] CCY-nVI-m [00323] CCY-nVI-Om [00324] CPY-V-n [00325] CPY-V-On [00326] CPY-nV-m [00327] CPY-nV-Om [00328] CPY-VI-m [00329] CPY-VI-Om [00330] CPY-nVI-k [00331] CPY-nVI-Om [00332] CY-n-m [00333] CY-n-Om [00334] CVY-n-m [00335] CVY-V-n [00336] CZY-n-Om [00337] COY-n-m [00338] COY-n-Om [00339] Y-n-m [00340] Y-n-Om [00341] Y-nO-Om [00342] PY-n-m [00343] PY-n-Om [00344] PY-nO-Om [00345] CCY-n-m [00346] CCY-n-Om [00347] CCY-n-mOl [00348] CCZY-n-Om [00349] CCOY-n-m [00350] CCOY-n-Om [00351] CLOY-n-Om [00352] CPY-n-m [00353] CPY-n-Om [00354] CGIY-n-Om [00355] PYP-n-m [00356] PYP-n-V [00357] PYP-n-IV [00358] PYP-n-Vm [00359] PYP-n-IVm [00360] PYP-n-(c5) [00361] PYP-n-m(c3) [00362] CLY-n-m [00363] CLY-n-Om [00364] CK-n-F [00365] B-n-m [00366] B-n-IV [00367] B-Vn-IV [00368] B-n-Om [00369] B-nO-Om [00370] CB-n-Om [00371] PB-n-Om [00372] B(S)-nO-Om [00373] COB(S)-n-Om [00374] B(S)-(c3)nO-Om [00375] B(S)-(c5)nO-Om [00376] B(S)-(c5-3en)nO-Om [00377] B(S)-(c5)nO-Om(c3) [00378] B(S)-(c5)IO-OmVn [00379] B(P)-n-m [00380] B(P)-n-Om [00381] B(P)-n-Om [00382] B(P)-nO-Om [00383] B(P)-(c5)nO-Om [00384] B(A)-nO-Om

TABLE-US-00005 TABLE E Table E shows illustrative reactive mesogenic compounds which can be used in the LC media in accordance with the present invention. [00385] RM-1 [00386] RM-2 [00387] RM-3 [00388] RM-4 [00389] RM-5 [00390] RM-6 [00391] RM-7 [00392] RM-8 [00393] RM-9 [00394] RM-10 [00395] RM-11 [00396] RM-12 [00397] RM-13 [00398] RM-14 [00399] RM-15 [00400] RM-16 [00401] RM-17 [00402] RM-18 [00403] RM-19 [00404] RM-20 [00405] RM-21 [00406] RM-22 [00407] RM-23 [00408] RM-24 [00409] RM-25 [00410] RM-26 [00411] RM-27 [00412] RM-28 [00413] RM-29 [00414] RM-30 [00415] RM-31 [00416] RM-32 [00417] RM-33 [00418] RM-34 [00419] RM-35 [00420] RM-36 [00421] RM-37 [00422] RM-38 [00423] RM-39 [00424] RM-40 [00425] RM-41 [00426] RM-42 [00427] RM-43 [00428] RM-44 [00429] RM-45 [00430] RM-46 [00431] RM-47 [00432] RM-48 [00433] RM-49 [00434] RM-50 [00435] RM-51 [00436] RM-52 [00437] RM-53 [00438] RM-54 [00439] RM-55 [00440] RM-56 [00441] RM-57 [00442] RM-58 [00443] RM-59 [00444] RM-60 [00445] RM-61 [00446] RM-62 [00447] RM-63 [00448] RM-64 [00449] RM-65 [00450] RM-66 [00451] RM-67 [00452] RM-68 [00453] RM-69 [00454] RM-70 [00455] RM-71 [00456] RM-72 [00457] RM-73 [00458] RM-74 [00459] RM-75 [00460] RM-76 [00461] RM-77 [00462] RM-78 [00463] RM-79 [00464] RM-80 [00465] RM-81 [00466] RM-82 [00467] RM-83 [00468] RM-84 [00469] RM-85 [00470] RM-86 [00471] RM-87 [00472] RM-88 [00473] RM-89 [00474] RM-90 [00475] RM-91 [00476] RM-92 [00477] RM-93 [00478] RM-94 [00479] RM-95 [00480] RM-96 [00481] RM-97 [00482] RM-98 [00483] RM-99 [00484] RM-100 [00485] RM-101 [00486] RM-102 [00487] RM-103 [00488] RM-104 [00489] RM-105 [00490] RM-106 [00491] RM-107 [00492] RM-108 [00493] RM-109 [00494] RM-110 [00495] RM-111 [00496] RM-112 [00497] RM-113 [00498] RM-114 [00499] RM-115 [00500] RM-116 [00501] RM-117 [00502] RM-118 [00503] RM-119 [00504] RM-120 [00505] RM-121 [00506] RM-122 [00507] RM-123 [00508] RM-124 [00509] RM-125 [00510] RM-126 [00511] RM-127 [00512] RM-128 [00513] RM-129 [00514] RM-130 [00515] RM-131 [00516] RM-132 [00517] RM-133 [00518] RM-134 [00519] RM-135 [00520] RM-136 [00521] RM-137 [00522] RM-138 [00523] RM-139 [00524] RM-140 [00525] RM-141 [00526] RM-142 [00527] RM-143 [00528] RM-144 [00529] RM-145 [00530] RM-146 [00531] RM-147 [00532] RM-148 [00533] RM-149 [00534] RM-150 [00535] RM-151 [00536] RM-152 [00537] RM-153 [00538] RM-154 [00539] RM-155 [00540] RM-156 [00541] RM-157 [00542] RM-158 [00543] RM-159 [00544] RM-160 [00545] RM-161 [00546] RM-162 [00547] RM-163 [00548] RM-164 [00549] RM-165 [00550] RM-166 [00551] RM-167 [00552] RM-168 [00553] RM-169 [00554] RM-170 [00555] RM-171 [00556] RM-172 [00557] RM-173 [00558] RM-174 [00559] RM-175 [00560] RM-176 [00561] RM-177 [00562] RM-178 [00563] RM-179 [00564] RM-180 [00565] RM-181 [00566] RM-182 [00567] RM-183 [00568] RM-184

[0615] In a preferred embodiment, the mixtures according to the invention comprise one or more polymerizable compounds, preferably selected from the polymerizable compounds of the formulae RM-1 to RM-182. Of these compounds, compounds RM-1, RM-4, RM-8, RM-17, RM-19, RM-35, RM-37, RM-39, RM-40, RM-41, RM-48, RM-52, RM-54, RM-57, RM-58, RM-64, RM-74, RM-76, RM-88, RM-91, RM-102, RM-103, RM-109, RM-116, RM-117, RM-120, RM-121, RM-122, RM-139, RM-140, RM-142, RM-143, RM-145, RM-146, RM-147, RM-149, RM-156 to RM-163, RM-169, RM-170, and RM-171 to RM-183 are particularly preferred.

EXAMPLES

[0616] The present invention is illustrated in detail by the following non-restrictive working examples.

[0617] The following abbreviations and symbols are used: [0618] V.sub.0 threshold voltage, capacitive [V] at 20 C., [0619] n.sub.e extraordinary refractive index at 20 C. and 589 nm, [0620] n.sub.o ordinary refractive index at 20 C. and 589 nm, [0621] n optical anisotropy at 20 C. and 589 nm, [0622] .sub. dielectric permittivity perpendicular to the director at 20 C. and 1 kHz, [0623] .sub. dielectric permittivity parallel to the director at 20 C. and 1 kHz, [0624] dielectric anisotropy at 20 C. and 1 kHz, [0625] cl.p., T(N,I) clearing point [ C.], [0626] .sub.1 rotational viscosity at 20 C. [mPa.Math.s], [0627] K.sub.1 elastic constant, splay deformation at 20 C. [pN], [0628] K.sub.2 elastic constant, twist deformation at 20 C. [pN], [0629] K.sub.3 elastic constant, bend deformation at 20 C. [pN].

[0630] Unless explicitly noted otherwise, all concentrations in the present application are quoted in percent by weight and relate to the corresponding mixture as a whole, comprising all solid or liquid-crystalline components, without solvents.

[0631] Unless explicitly noted otherwise, all temperature values indicated in the present application, such as, for example, for the melting point T(C,N), the transition from the smectic (S) to the nematic (N) phase T(S,N), and the clearing point T(N,I), are quoted in degrees Celsius ( C.). M.p. denotes melting point, and cl.p.=clearing point. Furthermore, C=crystalline state, N=nematic phase, S=smectic phase, and I=isotropic phase. The data between these symbols represent the transition temperatures.

[0632] All physical properties are and have been determined in accordance with Merck Liquid Crystals, Physical Properties of Liquid Crystals, Status November 1997, Merck KGaA, Germany, and under a temperature of 20 C., n is determined at 589 nm, and is measured at 1 kHz, unless explicitly indicated otherwise in each case.

[0633] The term threshold voltage for the present invention relates to the capacitive threshold (V.sub.0), also known as the Freedericks threshold, unless explicitly indicated otherwise. In the examples, the optical threshold may also, as generally usual, be quoted for 10% relative contrast (V.sub.10).

[0634] Unless stated otherwise, the process of polymerizing the polymerizable compounds in the PSA displays as described above and below is carried out at a temperature where the LC medium exhibits a liquid crystal phase, preferably a nematic phase, and most preferably is carried out at room temperature.

[0635] Unless stated otherwise, methods of preparing test cells and measuring their electro-optical and other properties are carried out by the methods as described hereinafter or in analogy thereto.

[0636] The display used for measurement of the capacitive threshold voltage consists of two plane-parallel glass outer plates with a distance of 25 m, each of which has on the inside an electrode layer and an unrubbed polyimide alignment layer on top, which effect homeotropic alignment of the liquid-crystal molecules.

[0637] The display or test cell used for measurement of the tilt angles consists of two plane-parallel glass outer plates at a separation of 4 m, each of which has on the inside an electrode layer and a polyimide alignment layer on top, where the two polyimide layers are rubbed antiparallel to one another and effect a homeotropic edge alignment of the liquid-crystal molecules.

[0638] The polymerizable compounds are polymerized in the display or test cell by irradiation with UV light of defined intensity for a prespecified time, with a voltage simultaneously being applied to the display (usually 10 V to 30 V alternating current, 1 kHz). In the examples, unless indicated otherwise, a fluorescent lamp and an intensity of 0 to 20 mW/cm.sup.2 is used for polymerization. The intensity is measured using a standard meter (Ushio Accumulate UV meter with central wavelength of 313 nm).

[0639] The transmission measurements are performed in test cells with fishbone electrode layout (from Merck Ltd., Japan; 1 pixel fishbone electrode (ITO, 1010 mm, 47.7 angle of fishbone with 3 m line/3 m space), 3.2 m cell gap, AF-glass, tilt angle 1).

[0640] The storage stability in the bulk (LTS.sub.bulk) of the media according to the invention at a given temperature T is determined by visual inspection. 2 g of the media of interest are filled into a closed glass vessel (bottle) of appropriate size placed in a refrigerator at a predetermined temperature. The bottles are checked at defined time intervals for the occurrence of smectic phases or crystallization. For every material and at each temperature two bottles are stored. If crystallization or the appearance of a smectic phase is observed in at least one of the two correspondent bottles, the test is terminated, and the time of the last inspection before the one at which the occurrence of a higher ordered phase is observed is recorded as the respective storage stability.

MIXTURE EXAMPLES

[0641] The following stabilizers are used:

##STR00569## ##STR00570##

[0642] The nematic LC host mixtures H1 to H16 and Mixture Examples N1 to N18 have the compositions and the properties given in the following tables.

TABLE-US-00006 Host Mixture H1 B(S)-2O-O5 1.0% T.sub.(N,I) [ C.]: 93.1 CC-3-V 32.0% n (589 nm, 25 C.): 0.0902 CC-3-V1 8.0% n.sub.e (25 C., 589.3 nm]: 1.5682 CC-3-5 1.5% n.sub.o (25 C., 589.3 nm]: 1.4780 CCY-3-O1 8.5% (1 kHz, 25 C.): 3.5 CCY-3-O2 9.0% .sub.|| (1 kHz, 25 C.): 3.5 CLY-3-O2 9.0% .sub. (1 kHz, 25 C.): 7.1 CLY-3-O3 5.0% K.sub.1 [pN], (25 C.): 16.3 CLY-4-O2 4.0% K.sub.3 [pN], (25 C.): 17.8 CLY-5-O2 5.0% .sub.1 [mPa .Math. s], (25 C.): 91 CPY-3-O2 9.5% V.sub.0 [V], (25 C.): 2.38 Y-4O-O4 7.5% 100.0%

TABLE-US-00007 Host Mixture H2 B(S)-2O-O4 2.5% T.sub.(N,I) [ C.]: 83.7 B(S)-2O-O5 4.0% n (589 nm, 25 C.): 0.0916 B(S)-2O-O6 1.5% n.sub.e (25 C., 589.3 nm]: 1.5714 CC-3-V 44.0% n.sub.o (25 C., 589.3 nm]: 1.4798 CC-3-V1 8.0% (1 kHz, 25 C.): 2.9 CCY-3-O2 8.0% .sub.|| (1 kHz, 25 C.): 3.4 CLY-3-O2 8.0% .sub. (1 kHz, 25 C.): 6.3 CLY-3-O3 7.5% K.sub.1 [pN], (25 C.): 15.0 CLY-4-O2 5.0% K.sub.3 [pN], (25 C.): 15.6 CPY-3-O2 5.0% .sub.1 [mPa .Math. s], (25 C.): 65 PYP-2-3 2.5% V.sub.0 [V], (25 C.): 2.45 Y-4O-O4 4.0% 100.0%

TABLE-US-00008 Host Mixture H3 B(S)-2O-O5 3.0% T.sub.(N,I) [ C.]: 98.9 CC-3-V 29.5% n (589 nm, 20 C.): 0.0922 CC-3-V1 8.0% n.sub.e (20 C., 589.3 nm]: 1.5716 CC-3-5 5.5% n.sub.o (20 C., 589.3 nm]: 1.4794 CCY-3-O1 6.0% (1 kHz, 20 C.): 3.9 CCY-3-O2 8.0% .sub.|| (1 kHz, 20 C.): 3.4 CLY-3-O2 9.0% .sub. (1 kHz, 20 C.): 7.3 CLY-3-O3 6.0% K.sub.1 [pN], (20 C.): 18.5 CLY-4-O2 5.0% K.sub.3 [pN], (20 C.): 19.2 CLY-5-O2 5.0% .sub.1 [mPa .Math. s], (20 C.): 132 COB(S)-2-O4 5.0% V.sub.0 [V], (20 C.): 2.34 CY-3-O2 10.0% 100.0%

TABLE-US-00009 Host Mixture H4 B(S)-2O-O5 4.0% T.sub.(N,I) [ C.]: 91.1 CC-3-V 34.0% n (589 nm, 25 C.): 0.0918 CC-3-V1 7.5% n.sub.e (25 C., 589.3 nm]: 1.5719 CCY-3-O1 4.5% n.sub.o (25 C., 589.3 nm]: 1.4801 CCY-3-O2 8.0% (1 kHz, 25 C.): 3.4 CLY-2-O4 5.0% .sub.|| (1 kHz, 25 C.): 3.7 CLY-3-O2 9.0% .sub. (1 kHz, 25 C.): 7.2 CLY-3-O3 8.0% K.sub.1 [pN], (25 C.): 16.8 CLY-4-O2 5.0% K.sub.3 [pN], (25 C.): 16.9 CLY-5-O2 5.0% .sub.1 [mPa .Math. s], (25 C.): 109 PYP-2-3 2.0% Y-4O-O4 6.0% CCU-2-F 2.0% 100.0%

TABLE-US-00010 Host Mixture H5 B(S)-(c5)1O-O2 1.0% T.sub.(N,I) [ C.]: 93.2 CC-3-V 32.0% n (589 nm, 25 C.): 0.0904 CC-3-V1 8.0% (1 kHz, 25 C.): 3.5 CC-3-5 1.5% CCY-3-O1 8.5% CCY-3-O2 9.0% CLY-3-O2 9.0% CLY-3-O3 5.0% CLY-4-O2 4.0% CLY-5-O2 5.0% CPY-3-O2 9.5% Y-4O-O4 7.5% 100.0%

TABLE-US-00011 Host Mixture H6 B(S)-2O-O4 2.5% T.sub.(N,I) [ C.]: 81.5 B(S)-2O-O5 4.0% n (589 nm, 25 C.): 0.0908 B(S)-2O-O6 1.5% (1 kHz, 25 C.): 3.0 CC-3-V 44.0% CC-3-V1 4.0% CC-1-2V1 4.0% CCY-3-O2 8.0% CLY-3-O2 8.0% CLY-3-O3 7.5% CLY-4-O2 5.0% CPY-3-O2 5.0% PYP-2-3 2.5% Y-4O-O4 4.0% 100.0%

TABLE-US-00012 Host Mixture H7 B(S)-2O-O4 2.5% T.sub.(N,I) [ C.]: 83 B(S)-2O-O5 4.0% n (589 nm, 25 C.): 0.0915 B(P)-4O-O4 1.5% (1 kHz, 25 C.): 2.8 CC-3-V 44.0% CC-3-V1 8.0% CCY-3-O2 8.0% CLY-3-O2 8.0% CLY-3-O3 7.5% CLY-4-O2 4.0% CY-(c5)-O2 1.0% CPY-3-O2 5.0% PYP-2-3 2.5% Y-4O-O4 4.0% 100.0%

TABLE-US-00013 Host Mixture H8 B(S)-(c5-3en)1O-O4 1.0% T.sub.(N,I) [ C.]: 93.2 CC-3-V 32.0% n (589 nm, 25 C.): 0.0898 CC-3-V1 8.0% (1 kHz, 25 C.): 3.5 CC-3-5 1.5% .sub.1 [mPa .Math. s], (25 C.): 91 CCY-3-O1 8.5% CCY-3-O2 9.0% CLY-3-O2 9.0% CLY-3-O3 5.0% CLY-4-O2 4.0% CLY-5-O2 5.0% CPY-3-O2 9.5% Y-4O-O4 7.5% 100.0%

TABLE-US-00014 Host Mixture H9 CC-3-V 32.0% T.sub.(N,I) [ C.]: 92 CC-3-V1 8.0% n (589 nm, 25 C.): 0.0888 CC-3-5 1.5% (1 kHz, 25 C.): 3.5 COY-3-O2 1.0% .sub.1 [mPa .Math. s], (25 C.): 89 CCY-3-O1 8.5% CCY-3-O2 9.0% CLY-3-O2 9.0% CLY-3-O3 5.0% CLY-4-O2 4.0% CLY-5-O2 5.0% CPY-3-O2 9.5% Y-4O-O4 7.5% 100.0%

TABLE-US-00015 Host Mixture H10 B(S)-2O-O5 1.0% T.sub.(N,I) [ C.]: 92 CC-3-V 32.0% n (589 nm, 25 C.): 0.0892 CC-3-V1 8.0% (1 kHz, 25 C.): 3.5 CC-3-5 1.5% .sub.1 [mPa .Math. s], (25 C.): 85 CCY-3-O1 8.5% CCY-3-O2 9.0% CLY-V-O2 4.0% CLY-3-O2 8.0% CLY-3-O3 4.0% CLY-4-O2 3.0% CLY-5-O2 4.0% CPY-3-O2 9.5% Y-4O-O4 7.5% 100.0%

TABLE-US-00016 Host Mixture H11 B(S)-2O-O5 3.0% T.sub.(N,I) [ C.]: 101 CC-3-V 31.5% n (589 nm, 20 C.): 0.0910 CC-3-V1 8.0% (1 kHz, 20 C.): 3.8 CC-2-3 5.5% .sub.1 [mPa .Math. s], (20 C.): 129 CCY-3-O1 6.0% CCY-3-O2 8.0% CLY-3-O2 9.0% CLY-3-O3 6.0% CLY-4-O2 5.0% CLY-5-O2 5.0% COB(S)-2-O4 5.0% CAIY-3-O2 3.0% CY-3-O2 5.0% 100.0%

TABLE-US-00017 Host Mixture H12 B(S)-2O-O5 3.0% T.sub.(N,I) [ C.]: 97 CC-3-V 31.5% n (589 nm, 20 C.): 0.0844 CC-3-V1 8.0% (1 kHz, 20 C.): 3.8 CC-1-2V1 3.0% .sub.1 [mPa .Math. s], (20 C.): 113 CC-2-3 5.5% COY-3-O2 5.0% CCY-3-O1 6.0% CCY-3-O2 8.0% CLY-3-O2 9.0% CLY-3-O3 6.0% CLY-4-O2 5.0% CLY-5-O2 5.0% CCOY-3-O2 5.0% 100.0%

TABLE-US-00018 Host Mixture H13 B(S)-2O-O5 3.0% T.sub.(N,I) [ C.]: 97 CC-3-V 31.5% n (589 nm, 20 C.): 0.0831 CC-3-V1 8.0% (1 kHz, 20 C.): 3.5 CC-1-2V1 3.0% .sub.1 [mPa .Math. s], (20 C.): 106 CC-2-3 5.5% CEY-3-O2 5.0% CCY-3-O1 6.0% CCY-V-O2 8.0% CLY-3-O2 9.0% CLY-3-O3 6.0% CLY-4-O2 5.0% CLY-5-O2 5.0% CCEY-3-O2 5.0% 100.0%

TABLE-US-00019 Host Mixture H14 B(A)-2O-O3 4.0% T.sub.(N,I) [ C.]: 92 CC-3-V 34.0% n (589 nm, 25 C.): 0.0917 CC-3-V1 7.5% (1 kHz, 25 C.): 3.5 CCY-3-O1 4.5% .sub.1 [mPa .Math. s], (25 C.): 109 CCY-3-O2 8.0% CLY-2-O4 5.0% CLY-3-O2 9.0% CLY-3-O3 8.0% CLY-4-O2 5.0% CLY-5-O2 5.0% PYP-2-3 2.0% Y-4O-O4 6.0% CCG-V-F 2.0% 100.0%

TABLE-US-00020 Host Mixture H15 B(S)-2O-O5 4.0% T.sub.(N,I) [ C.]: 93 CC-3-V 34.0% n (589 nm, 25 C.): 0.0934 CC-3-V1 7.5% (1 kHz, 25 C.): 3.4 CCY-3-O1 4.0% .sub.1 [mPa .Math. s], (25 C.): 115 CCY-3-O2 8.0% CLY-2-O4 5.0% CLY-3-O2 9.0% CLY-3-O3 8.0% CLY-4-O2 5.0% CLY-5-O2 5.0% PYP-2-(c5) 1.0% PYP-2-1(c3) 1.0% Y-4O-O4 6.0% CCG-V-F 2.0% PPGU-(c5)-F 0.5% 100.0%

TABLE-US-00021 Host Mixture H16 B(S)-2O-O5 4.0% T.sub.(N,I) [ C.]: 90 CC-3-V 34.0% n (589 nm, 25 C.): 0.0868 CC-3-V1 7.5% (1 kHz, 25 C.): 3.4 CCY-3-O1 4.5% .sub.1 [mPa .Math. s], (25 C.): 107 CCY-3-O2 8.0% CLY-2-O4 4.0% CLY-3-O2 8.0% CLY-3-O3 7.0% CLY-4-O2 4.0% CLY-5-O2 4.0% CCP-1-2V1 2.0% Y-4O-O4 6.0% COYOIC-3-3 5.0% CCU-2-F 2.0% 100.0%

TABLE-US-00022 Comparative Example C1 H1 99.96% ST-1c 0.03% la-1-1-1 0.01% 100.0%

TABLE-US-00023 Comparative Example C2 H1 99.96% ST-1c 0.03% lb-1-1-1 0.01% 100.0%

TABLE-US-00024 Comparative Example C3 H3 99.94% ST-1c 0.03% lb-2-1-1 0.01% 100.0%

TABLE-US-00025 Comparative Example C4 H1 99.96% ST-1c 0.03% lb-1-2-1 0.01% 100.0%

TABLE-US-00026 Mixture Example N1 H1 99.95% ST-1c 0.03% lb-1-1-1 0.01% la-1-1-1 0.01% 100.0%

TABLE-US-00027 Mixture Example N2 H1 99.93% ST-1c 0.03% lb-2-1-1 0.03% la-1-1-1 0.01% 100.0%

TABLE-US-00028 Mixture Example N3 H1 99.95% ST-1c 0.03% lb-1-2-1 0.01% la-1-1-1 0.01% 100.0%

TABLE-US-00029 Comparative Example C5 H1 99.94% ST-2c 0.05% lb-1-1-1 0.01% 100.0%

TABLE-US-00030 Comparative Example C6 H1 99.94% ST-2c 0.05% lb-1-1-1 0.01% 100.0%

TABLE-US-00031 Comparative Example C7 H1 99.92% ST-2c 0.05% lb-2-1-1 0.03% 100.0%

TABLE-US-00032 Comparative Example C8 H1 99.94% ST-2c 0.05% lb-1-2-1 0.01% 100.0%

TABLE-US-00033 Mixture Example N4 H1 99.93% ST-2c 0.05% lb-1-1-1 0.01% la-1-1-1 0.01% 100.0%

TABLE-US-00034 Mixture Example N5 H1 99.91% ST-2c 0.05% lb-2-1-1 0.03% la-1-1-1 0.01% 100.0%

TABLE-US-00035 Mixture Example N6 H1 99.93% ST-2c 0.05% lb-1-2-1 0.01% la-1-1-1 0.01% 100.0%

TABLE-US-00036 Mixture Example N7 H2 99.95% ST-1c 0.03% lb-1-1-1 0.01% la-1-1-1 0.01% 100.0%

TABLE-US-00037 Mixture Example N8 H2 99.93% ST-1c 0.03% lb-2-1-1 0.03% la-1-1-1 0.01% 100.0%

TABLE-US-00038 Mixture Example N9 H2 99.95% ST-1c 0.03% lb-1-2-1 0.01% la-1-1-1 0.01% 100.0%

TABLE-US-00039 Mixture Example N10 H3 99.95% ST-1c 0.03% lb-1-1-1 0.01% la-1-1-1 0.01% 100.0%

TABLE-US-00040 Mixture Example N11 H3 99.93% ST-1c 0.03% lb-2-1-1 0.03% la-1-1-1 0.01% 100.0%

TABLE-US-00041 Mixture Example N12 H3 99.95% ST-1c 0.03% lb-1-2-1 0.01% la-1-1-1 0.01% 100.0%

TABLE-US-00042 Mixture Example N13 H4 99.95% ST-1c 0.03% lb-1-1-1 0.01% la-1-1-1 0.01% 100.0%

TABLE-US-00043 Mixture Example N14 H4 99.93% ST-1c 0.03% lb-2-1-1 0.03% la-1-1-1 0.01% 100.0%

TABLE-US-00044 Mixture Example N15 H4 99.95% ST-1c 0.03% lb-1-2-1 0.01% la-1-1-1 0.01% 100.0%

TABLE-US-00045 Mixture Example N16 H13 99.95% ST-1g 0.03% lb-1-1-1 0.01% la-1-1-1 0.01% 100.0%

TABLE-US-00046 Mixture Example N17 H14 99.95% ST-1g 0.02% ST-3a 0.01% lb-1-1-1 0.01% la-1-1-1 0.01% 100.0%

TABLE-US-00047 Mixture Example N18 H15 99.95% ST-3b 0.03% lb-1-1-1 0.01% la-1-1-1 0.01% 100.0%

Stress Tests

[0643] Backlight and heat stress tests have been performed with the above mixtures as follows. Test cells (AF glass, 1 cm1 1 cm ITO electrodes, cell gap 3.5 m) with a polyimide alignment layer (JSR3225, Japan Synthetic Rubber (JSR), Japan, layer thickness 65 nm, rubbed) are filled with the corresponding mixtures, and their voltage holding ratio is measured before and after irradiation using the measurement system Model 6254 from Toyo Corporation, Japan. The test cells are irradiated by exposure to commercial LCD TV white backlight (CCFL) without filter. The temperature of the test cells during the irradiation was about 50 C. due to the heat evolution of the backlight. The VHR is determined at 60 C. and after 30 minutes storage. The voltage is 1 V at a frequency of 60 Hz, and 3 Hz, respectively. The results are summarised in the following table 1 and table 2.

TABLE-US-00048 TABLE 1 VHR values after backlight load.sup.[1] Mixture t [h] H1 C1 C2 C3 C4 N1 N2 N3 0 99.1 98.6 98.0 98.6 97.9 97.7 98.9 97.5 24 96.1 98.6 98.4 98.2 98.1 99.1 99.5 98.9 48 92.2 96.8 97.9 97.7 98.7 99.5 98.7 120 96.2 312 79.2 91.7 93.5 92.4 97.2 99.1 97.2 .sup.[1]measured at 60 Hz, 60 C.

TABLE-US-00049 TABLE 2 VHR values after backlight load.sup.[2] Mixture t [h] H1 C1 C2 C3 C4 N1 N2 N3 0 95.2 93.8 83.9 92.5 81.2 82.1 91.9 78.3 24 89.5 95.4 90.8 94.8 88.1 92.7 96.6 90.7 48 80.4 91.5 91.2 89.4 92.3 96.6 91.4 120 88.5 312 41.3 79.2 82.2 78.9 90.8 93.4 90.0 .sup.[2]measured at 3 Hz, 60 C.

[0644] The VHR after backlight load of the host mixture H1 without stabilizer can be improved by addition of a stabilizer of the formula ST and a second stabilizer of the formula Ia or Ib (Mixtures C1 to C4).

[0645] Surprisingly, the VHR can be further significantly improved by use of a combination of three stabilizers of the formulae ST and Ia and Ib (Mixtures N1, N2, and N3).